Vísindastarf

Krabbameinsfélagið gegnir miklu hlutverki í að afla nýrrar þekkingar í heilbrigðisvísindum.

Vísindaefni

Útgefið vísindaefni 2022

Ssenyonga N, Stiller C, Nakata K, Shalkow J, Redmond S, Bulliard J-L et al. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. Lancet Child Adolesc Health 2022;6(6):409-431.
Torfadottir JE, Einarsdottir SE, Helgason AR, Thorisdottir B, Gudmundsdottir RB, Unnarsdottir AB, Tryggvadottir L, Birgisson H, Thorvaldsdottir GH. [Cohort study on the experiences of cancer diagnosis and treatment in Iceland in the year 2015-2019]. Laeknabladid. 2022 Oct;108(10):447-454.
Johansson ALV, Larønningen S, Skovlund CW, Kristiansen MF, Mørch LS, Friis S, Johannesen TB, Myklebust TÅ, Skog A, Pettersson D, Birgisson H, Virtanen A, Malila N, Pitkäniemi J, Tanskanen T, Tryggvadóttir L, Ursin G, Lambe M. The impact of the COVID-19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020. Int J Cancer. 2022 Aug 1;151(3):381-395.
Kauppila JH, Santoni G, Tao W, Lynge E, Jokinen J, Tryggvadóttir L, Ness-Jensen E, Pukkala E, von Euler-Chelpin M, Lagergren J. Risk Factors for Suicide After Bariatric Surgery in a Population-based Nationwide Study in Five Nordic Countries. Ann Surg. 2022;33(2):205-211.
Thordardottir GS, Einarsdottir K, Thordardottir M, Tryggvadottir L, Valdimarsdottir UA, Gudnason V, Steingrimsdottir L, Aspelund T, Birgisdottir BE, Torfadottir JE. Dietary patterns in adolescence and risk of colorectal cancer: a population-based study. Cancer Causes Control. 2022 Nov 20. doi: 10.1007/s10552-021-01524-z. Online ahead of print.
Haraldsdottir A, Steingrimsdottir L, Maskarinec G, Adami HO, Aspelund T, Valdimarsdottir UA, Bjarnason R, Thorsdottir I, Halldorsson TI, Gunnarsdottir I, Tryggvadottir L, Gudnason V, Birgisdottir BE, Torfadottir JE. Growth Rate in Childhood and Adolescence and Risk of Breast and Prostate Cancer: A Population-Based Study. Am J Epidemiol. 2022 Jan 24;191(2):320-330.
Frida E Lundberg, Helgi Birgisson, Tom Børge Johannesen, Gerda Engholm, Anni Virtanen, David Pettersson, Elínborg J Ólafsdóttir, Mats Lambe, Paul C Lambert, Lina Steinrud Mørch, Anna L V Johansson, Therese M-L Andersson. Survival trends in patients diagnosed with colon and rectal cancer in the Nordic countries 1990-2016: The NORDCAN Survival Studies Accepted in European Journal of Cancer 2022; 172: 76-84.
Rakel Hekla Sigurðardóttir, Helgi Birgisson, Jón Gunnlaugur Jónasson, Kristín Huld Haraldsdóttir. Liver surgeries in Iceland 2013-2017 - Comparison with Sweden in terms of quality registration Laeknabladid 2022;108(9):395-402.
Claudia Vener, Silvia Rossi, Pamela Minicozzi, Rafael Marcos-Gragera , Hélène A Poirel, Marc Maynadié, Xavier Troussard, Gabriella Pravettoni, Roberta De Angelis, Milena Sant, EUROCARE-6 Working Group (Helgi Birgisson corporate author). Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials. Front Oncol 2022 Jul 14;12:892684. doi: 10.3389/fonc.2022.892684. eCollection 2022.
Pettersson AK, Santoni G, Yan J, Radkiewicz C, Xie S, Birgisson H, Ness-Jensen E, von Euler-Chelpin M, Kauppila JH, Lagergren J. Cohort profile: Nordic Helicobacter Pylori eradication project (NordHePEP) Scand J Gastroenterol 2022; 108 (10): 447-454.
Laura Botta, Gemma Gatta, Riccardo Capocaccia, Charles Stiller, Adela Cañete, Luigino Dal Maso, Kaire Innos, Ana Mihor, Friederike Erdmann, Claudia Spix, Brigitte Lacour, Rafael Marcos-Gragera, Deirdre Murray, Silvia Rossi, on behalf of the EUROCARE-6 Working Group*(Helgi Birgisson corporate author). Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a populationbased study. Lancet Oncol 2022; 23; 1525-36.
Elena Demuru, Silvia Rossi, Leonardo Ventura, Luigino Dal Maso, Stefano Guzzinati, Alexander Katalinic, Sebastien Lamy, Valerie Jooste, Corrado Di Benedetto, Roberta De Angelis; EUROCARE-6 Working Group (Helgi Birgisson corporate author). Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes Front Oncol 2023 Apr 24;13:1114701. doi: 10.3389/fonc.2023.1114701. eCollection 2023

Útgefið vísindaefni 2011-2021

Útgefið vísindaefni 2021

Oskarsson T, Duun-Henriksen AK, Bautz A, Montgomery S, Harila-Saari A, Petersen C, Niinimäki R, Madanat-Harjuoja L, Tryggvadóttir L, Holmqvist AS, Hasle H, Heyman M, Winther JF; ALiCCS study group. Skeletal adverse events in childhood cancer survivors: An Adult Life after Childhood Cancer in Scandinavia cohort study. Int J Cancer 2021;149(11):1863-1876.
Maret-Ouda J, Santoni G, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J. Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic Countries. Ann Surg. 2021 Dec 1;274(6):e535-e540.
Thordardottir GS, Einarsdottir K, Thordardottir M, Tryggvadottir L, Valdimarsdottir UA, Gudnason V, Steingrimsdottir L, Aspelund T, Birgisdottir BE, Torfadottir JE. Dietary patterns in adolescence and risk of colorectal cancer: a population-based study. Cancer Causes Control. 2021 Nov 20. doi: 10.1007/s10552-021-01524-z. Online ahead of print.
Licht SF, Rugbjerg K, Andersen EW, Nielsen TT, Norsker FN, Kenborg L, Holmqvist AS, Madanat-Harjuoja LM, Tryggvadottir L, Stovall M, Wesenberg F, Hjorth L, Hasle H, Winther JF; Adult Life After Childhood Cancer in Scandinavia Study Group. Temporal changes in the probability of live birth among female survivors of childhood cancer: A population-based Adult Life After Childhood Cancer in Scandinavia (ALiCCS) study in five nordic countries. Cancer. 2021 Oct 15;127(20):3881-3892.
Haraldsdottir A, Steingrimsdottir L, Maskarinec G, Adami HO, Aspelund T, Valdimarsdottir UA, Bjarnason R, Thorsdottir I, Halldorsson TI, Gunnarsdottir I, Tryggvadottir L, Gudnason V, Birgisdottir BE, Torfadottir JE. Growth Rate in Childhood and Adolescence and Risk of Breast and Prostate Cancer: A Population-Based Study. Am J Epidemiol. 2021 Oct 13:kwab250. doi: 10.1093/aje/kwab250. Online ahead of print.Adalsteinsson JA,
Birgisson H, Olafsdottir EJ, Sverrisdottir A, Einarsson S, Smaradottir A, Tryggvadottir L. [Screening for cancer of the colon and rectum A review on incidence, mortality, cost and benefit]. Laeknabladid. 2021 Sep;107(9):398-405. doi: 10.17992/lbl.2021.09.65.
Adalsteinsson JA, Muzumdar S, Waldman R, Hu C, Wu R, Ratner D, Feng H, Ungar J, Silverberg JI, Olafsdottir GH, Kristjansson AK, Tryggvadottir L, Jonasson JG. Statins are associated with increased risk of squamous cell carcinoma of the skin: a whole-population study from Iceland. Arch Dermatol Res. 2021 Mar 27.
Yanes M, Santoni G, Maret-Ouda J, Ness-Jensen E, Färkkilä M, Lynge E, Pukkala E, Romundstad P, Tryggvadóttir L, -Chelpin MVE, Lagergren J. Survival after antireflux surgery versus medication in patients with reflux oesophagitis or Barrett's oesophagus: multinational cohort study. Br J Surg. 2021 Mar 16
Adalsteinsson JA, Muzumdar S, Waldman R, Wu R, Ratner D, Feng H, Ungar J, Silverberg JI, Olafsdottir GH, Kristjansson AK, Tryggvadottir L, Jonasson JG. Metformin is associated with decreased risk of basal cell carcinoma: A whole-population case-control study from Iceland. J Am Acad Dermatol. 2021 Feb 19
Adalsteinsson JA, Olafsdottir E, Ratner D, Waldman R, Feng H, Ungar J, Silverberg JI, Kristjansson AK, Jonasson JG, Tryggvadottir L. Invasive and in situ squamous cell carcinoma of the skin: a nationwide study in Iceland. Br J Dermatol. 2021 Sep;185(3):537-547.
Pedersen C, Rechnitzer C, Andersen EAW, Kenborg L, Norsker FN, Bautz A, Baad-Hansen T, Tryggvadottir L, Madanat-Harjuoja LM, Holmqvist AS, Hjorth L, Hasle H, Winther JF, On Behalf Of The ALiCCS Study Group. Somatic Disease in Survivors of Childhood Malignant Bone Tumors in the Nordic Countries. Cancers (Basel). 2021 Sep 7;13(18):4505.
Olafsdottir T, Stacey SN, Sveinbjornsson G, Thorleifsson G, Norland K, Sigurgeirsson B et al. , Thorisdottir K, Kristjansson AK, Tryggvadottir L, Sarin KY, Benediktsson R, Jonasson JG, Sigurdsson A, Jonasdottir A, Kristmundsdottir S, Jonsson H, Gylfason A, Oddsson A, Fridriksdottir R, Gudjonsson SA, Zink F, Lund SH, Rognvaldsson S, Melsted P, Steinthorsdottir V, Gudmundsson J, Mikaelsdottir E, Olason PI, Stefansdottir L, Eggertsson HP, Halldorsson BV, Thorsteinsdottir U, Agustsson TT, Olafsson K, Olafsson JH, Sulem P, Rafnar T, Gudbjartsson DF, Stefansson K. Loss-of-Function Variants in the Tumor-Suppressor Gene PTPN14 Confer Increased Cancer Risk. Cancer Res. 2021 Apr 15;81(8):1954-1964.
Yanes M, Santoni G, Maret-Ouda J, Markar S, Ness-Jensen E, Kauppila J, Färkkilä M, Lynge E, Pukkala E, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J. Mortality, Reoperation, and Hospital Stay Within 90 Days of Primary and Secondary Antireflux Surgery in a Population-Based Multinational Study. Gastroenterology. 2021 Feb 13.
Sacchetto L, Rosso S, Comber H, Bouchardy C, Broganelli P, Galceran J, Hackl M, Katalinic A, Louwman M, Robsahm TE, Tryggvadottir L, Tumino R, Van Eycken E, Walsh PM, Zadnik V, Zanetti R. Skin melanoma deaths within 1 or 3 years from diagnosis in Europe. Int J Cancer 2021 Jan 26.
Høgsholt S, Asdahl PH, Bonnesen TG, Holmqvist AS, Madanat-Harjuoja L, Tryggvadottir L, Bautz A, Albieri V, Green D, Winther JF, Hasle H. Disease-specific hospitalizations among 5-year survivors of Wilms tumor: A Nordic population-based cohort study. Pediatr Blood Cancer. 2021 Jan 23
Adalsteinsson JA, Muzumdar S, Waldman R, Hu C, Wu R, Ratner D, Ungar J, Silverberg JI, Olafsdottir GH, Kristjansson AK, Tryggvadottir L, Jonasson J. Anti-Tumor Necrosis Factor Therapy is Associated with Increased In-Situ Squamous Cell Carcinoma of the Skin: A Population-Based Case-Control Study. J Am Acad Dermatol. 2021 Jun;84(6):1760-1762.
Nygård M, Hansen BT, Kjaer SK, Hortlund M, Tryggvadóttir L, Munk C, Lagheden C, Sigurdardottir LG, Campbell S, Liaw KL, Dillner J. Human papillomavirus genotype-specific risks for cervical intraepithelial lesions. Hum Vaccin Immunother. Hum Vaccin Immunother. 2021 Apr 3;17(4):972-981.
Frida E Lundberg, Therese M-L Andersson, Mats Lambe, Gerda Engholm, Lina Steinrud Mørck, Tom Børge Johannesen, Anni Virtanen, David Pettersson, Elínborg J Ólafsdóttir, Helgi Birgisson, Anna L V Johansson, Paul C Lambert Trends in cancer survival in the Nordic countries 1990-2016 Acta Oncologica 2020; 59(11): 1266-1274.

Útgefið vísindaefni 2020

Olafsdottir EJ, Borg A, Jensen MB, Gerdes AM, Johansson ALV, Barkardottir RB, Johannsson OT, Ejlertsen B, Sønderstrup IMH, Hovig E, Lænkholm AV, Hansen TVO, Olafsdottir GH, Rossing M, Jonasson JG, Sigurdsson S, Loman N, Nilsson MP, Narod SA, Tryggvadottir L. Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status. Br J Cancer. 2020 Sep 17.
Gisladottir LD, Birgisson H, Agnarsson BA, Jonsson T, Tryggvadottir L, Sverrisdottir A. [Comparison of diagnosis and treatment of invasive breast cancer between Iceland and Sweden]. Laeknabladid. 2020 Sep;106(9):397-402.
Yanes M, Santoni G, Maret-Ouda J, Ness-Jensen E, Färkkilä M, Lynge E, Nwaru B, Pukkala E, Romundstad P, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J. Antireflux surgery and risk of lung cancer by histological type in a multinational cohort study. Eur J Cancer. 2020 Aug 30;138:80-88.
Adalsteinsson JA, Muzumdar S, Waldman R, Hu C, Wu R, Ratner D, Ungar J, Silverberg JI, Olafsdottir GH, Kristjansson AK, Tryggvadottir L, Jonasson J. Association between Hydrochlorothiazide and the Risk of In-situ and Invasive Squamous Cell Skin Carcinoma and Basal Cell Carcinoma: A Population-Based Case-Control Study. J Am Acad Dermatol. 2020 Aug 10:S0190-9622(20)32413-0.
Norsker FN, Boschini C, Rechnitzer C, Holmqvist AS, Tryggvadottir L, Madanat-Harjuoja LM, Schrøder H, Scheike TH, Hasle H, Winther JF, Andersen KK; ALiCCS study group. Risk of late health effects after soft-tissue sarcomas in childhood - a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia research programme. Acta Oncol. 2020 Jul 21:1-11.
Kauppila JH, Santoni G, Tao W, Lynge E, Jokinen J, Tryggvadóttir L, Ness-Jensen E, Pukkala E, von Euler-Chelpin M, Lagergren J. Risk Factors for Suicide After Bariatric Surgery in a Population-based Nationwide Study in Five Nordic Countries. Ann Surg. 2020 Jul 9.
Kjaer SK, Nygård M, Sundström K, Dillner J, Tryggvadottir L, Munk C, Berger S, Enerly E, Hortlund M, Ágústsson ÁI, Bjelkenkrantz K, Fridrich K, Guðmundsdóttir I, Sørbye SW, Bautista O, Group T, Luxembourg A, Marshall JB, Radley D, Yang YS, Badshah C, Saah A. Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries. EClinicalMedicine. 2020 Jun 20;23:100401.
Tao W, Santoni G, von Euler-Chelpin M, Ljung R, Lynge E, Pukkala E, Ness-Jensen E, Romundstad P, Tryggvadottir L, Lagergren J. Cancer Risk After Bariatric Surgery in a Cohort Study from the Five Nordic Countries. Obes Surg. 2020 Jun 13.
Enerly E, Berger S, Kjær SK, Sundström K, Campbell S, Tryggvadóttir L, Munk C, Hortlund M; Thomas Group, Joshi A, Saah AJ, Nygård M. Use of real-world data for HPV vaccine trial follow-up in the Nordic region. Contemp Clin Trials. 2020 Apr 1;92:105996
Kauppila JH, Santoni G, Tao W, Lynge E, Koivukangas V, Tryggvadóttir L, Ness-Jensen E, Romundstad P, Pukkala E, von Euler-Chelpin M, Lagergren J. Reintervention or mortality within 90 days of bariatric surgery: population-based cohort study. Br J Surg. 2020 Apr 1.
Stefansson OA, Hilmarsdottir H, Olafsdottir K, Tryggvadottir L, Sverrisdottir A, Johannsson OT, Jonasson JG, Eyfjord JE, Sigurdsson S. BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy. JNCI Cancer Spectr. 2019 Dec 11;4(2):pkz100.
Adalsteinsson JA, Ratner D, Olafsdóttir E, Grant-Kels J, Ungar J, Silverberg JI, Kristjansson AK, Jonasson JG, Tryggvadottir L. Basal cell carcinoma: an emerging epidemic in women in Iceland. Br J Dermatol. 2020 Feb 7.
Michalek IM, Kinnunen TI, Kjaerheim K, Lynge E, Martinsen JI, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E. Smoking-adjusted risk of kidney cancer by occupation: a population-based cohort study of Nordic men. Acta Oncol. 2020 Feb 3:1-6
Ugelvig Petersen K, Pukkala E, Martinsen JI, Lynge E, Tryggvadottir L, Weiderpass E, Kjærheim K, Heikkinen S, Hansen J. Cancer incidence among seafarers and fishermen in the Nordic countries. Scand J Work Environ Health 2020 Jan 9.
Bielska-Lasota M, Rossi S, Krzyżak M et al (Birgisson H as one of collaborators) EUROCARE-5 Working Group. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study. Arch Gynecol Obstet 2020; 301(2): 591-602.
Arnar S. Agustsson, Helgi Birgisson, Bjarni A. Agnarsson, Thorvaldur Jonsson, Hrefna Stefansdottir, Mats Lambe, Laufey Tryggvadottir and Asgerdur Sverrisdottir. In situ breast cancer in Iceland: 60-year incidence and differences in Ductal Carcinoma In Situ treatment to Sweden. Scientific Reports 2020; 10(1): 17623.
Luigino Dal Maso , Chiara Panato , Andrea Tavilla ,et al (Birgisson H as one of collaborators) EUROCARE-5 Working Group. Cancer cure for 32 cancer types: results from the EUROCARE-5 study. Int J Epidemiol 2020;49(5):1517-1525.
Nakata K, Colombet M, Stiller CA, Pritchard-Jones K, Steliarova-Foucher E (Birgisson H as one of collaborators) IICC-3 contributors. Incidence of childhood renal tumours: an international population‐based study. International Journal of Cancer. 2020;147(12):3313-3327.
Bielska-Lasota M, Rossi S, Krzyżak M et al (Birgisson H as one of collaborators) EUROCARE-5 Working Group. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study. Arch Gynecol Obstet 2020; 301(2): 591-602.

Útgefið vísindaefni 2019

Bielska-Lasota M, Rossi S, Krzyżak M, Haelens A, Domenic A, De Angelis R, Maciejczyk A, Rodríguez-Barranco M, Zadnik V, Minicozzi P; EUROCARE-5 Working Group. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study. Arch Gynecol Obstet. 2019 Dec 18. doi: 10.1007/s00404-019-05412-5
Maret-Ouda J, Santoni G, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J. Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic Countries. Ann Surg. 2019 Nov 27. doi: 10.1097/SLA.0000000000003709
Tao W, Artama M, von Euler-Chelpin M, Hull M, Ljung R, Lynge E, Ólafsdóttir GH, Pukkala E, Romundstad P, Talbäck M, Tryggvadottir L, Lagergren J. Colon and rectal cancer risk after bariatric surgery in a multicountry Nordic cohort study. Int J Cancer. 2019 Dec 3. doi: 10.1002/ijc.32770
Noh H, Charvat H, Freisling H, Ólafsdóttir GH, Ólafsdóttir EJ, Tryggvadóttir L, Arnold M, Soerjomataram I. Cumulative exposure to premenopausal obesity and risk of postmenopausal cancer: A population-based study in Icelandic women. Int J Cancer. 2019 Nov 21. doi: 10.1002/ijc.32805
Norsker FN, Rechnitzer C, Andersen EW, Linnet KM, Kenborg L, Holmqvist AS, Tryggvadottir L, Madanat-Harjuoja LM, Øra I, Thorarinsdottir HK, Vettenranta K, Bautz A, Schrøder H, Hasle H, Winther JF. Neurologic disorders in long-term survivors of neuroblastoma - a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) research program. Acta Oncol. 2019 Oct 8:1-7. doi: 10.1080/0284186X.2019.1672892
Talibov M, Hansen J, Heikkinen S, Martinsen JI, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E. Occupational exposures and male breast cancer: A nested case-control study in the Nordic countries. Breast. 2019 Sep 12;48:65-72. doi: 10.1016/j.breast.2019.09.004
Michalek IM, Kjærheim K, Martinsen JI, Sparén P, Tryggvadóttir L, Weiderpass E, Pukkala E, Lynge E. Smoking-adjusted risk of renal pelvis cancer by occupation: a population-based cohort study of Nordic men. Acta Oncol. 2019 Sep 20:1-4. doi: 10.1080/0284186X.2019.1667024.
Feldman I, Helgason AR, Johansson P, Tegelberg Å, Nohlert E. Cost-effectiveness of a high-intensity versus a low-intensity smoking cessation intervention in a dental setting: long-term follow-up. BMJ Open. 2019 Aug 15;9(8):e030934. doi: 10.1136/bmjopen-2019-030934
Maskarinec G, Haraldsdóttir Á, Einarsdóttir K, Aspelund T, Tryggvadóttir L, Harris TB, Gudnason V, Torfadóttir JE. Type 2 diabetes and obesity in midlife and breast cancer risk in the Reykjavik cohort. Cancer Causes Control. 2019 Aug 10. doi: 10.1007/s10552-019-01213-y.
Frick E, Gudjonsson T, Eyfjord J, Jonasson J, Tryggvadóttir L, Stefansson O, Sigurdsson S. CpG promoter hypo-methylation and up-regulation of microRNA-190b in hormone receptor-positive breast cancer. Oncotarget. 2019 Jul 23;10(45):4664-4678.
Talibov M, Sormunen J, Weiderpass E, Kjaerheim K, Martinsen JI, Sparen P, Tryggvadottir L, Hansen J, Pukkala E. Workplace Diesel Exhausts and Gasoline Exposure and Risk of Colorectal Cancer in Four Nordic Countries. Saf Health Work. 2019 Jun;10 (2):141-150.
Torfadottir JE, Aspelund T. Sjálfbært mataræði til bjargar [Flexitarian diet to the rescue]. Laeknabladid. 2019 Jun;105(6):264-265. doi: doi.org/10.17992/lbl.2019.06.234. Icelandic. PubMed PMID: 31192788.
Dickerman BA, Torfadottir JE, Valdimarsdottir UA, Giovannucci E, Wilson KM, Aspelund T, Tryggvadottir L, Sigurdardottir LG, Harris TB, Launer LJ, Gudnason V, Markt SC, Mucci LA. Body fat distribution on computed tomography imaging and prostate cancer risk and mortality in the AGES-Reykjavik study. Cancer. 2019 Aug 15;125 (16):2877-2885.
Partanen VM, Anttila A, Heinävaara S, Pankakoski M, Sarkeala T, Bzhalava Z, Elfström KM, Tropé A, Skare GB, Thorsteinsdottir S, Ágústsson ÁI, Veerus P, Koreinik L, Dillner J, Lönnberg S. NordScreen - an interactive tool for presenting cervical cancer screening indicators in the Nordic countries. Acta Oncol. 2019 May 20:1-6. doi: 10.1080/0284186X.2019.1615637. [Epub ahead of print] PubMed PMID: 31106635.
Kenborg L, Linnet KM, de Fine Licht S, Bautz A, Holmqvist AS, Tryggvadottir L, Madanat-Harjuoja LM, Stovall M, Heilmann C, Albieri V, Hasle H, Winther JF; ALiCCS study group. Hospital admission for neurologic disorders among 5-year survivors of noncentral nervous system tumors in childhood: A cohort study within the Adult Life after Childhood Cancer in Scandinavia study. Int J Cancer. 2019 Apr 13.
Kauppila JH, Tao W, Santoni G, von Euler-Chelpin M, Lynge E, Tryggvadóttir L, Ness-Jensen E, Romundstad P, Pukkala E, Lagergren J. Effects of Obesity Surgery on Overall and Disease-Specific Mortality in a 5-Country Population-Based Study. Gastroenterology. 2019 Mar 30. pii: S0016-5085(19)34648-7.
Michalek IM, Martinsen JI, Weiderpass E, Hansen J, Sparen P, Tryggvadottir L, Pukkala E. Heavy metals, welding fumes, and other occupational exposures, and the risk of kidney cancer: A population-based nested case-control study in three Nordic countries. Environ Res. 2019 Jun;173:117-123.
Torfadottir JE, Aspelund T, Valdimarsdottir UA, Cotch MF, Tryggvadottir L, Harris TB, Gudnason V, Adami HO, Mucci LA, Giovannucci EL, Stampfer MJ, Steingrimsdottir L. Pre-diagnostic 25-hydroxyvitamin D levels and survival in cancer patients. Cancer Causes Control. 2019 Apr;30(4):333-342.
Sørensen GV, Winther JF, de Fine Licht S, Andersen KK, Holmqvist AS, Madanat-Harjuoja L, Tryggvadottir L, Bautz A, Lash TL, Hasle H. Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries. J Natl Cancer Inst. 2019
Andersson TM, Engholm G, Lund AQ, Lourenço S, Matthiessen J, Pukkala E, Stenbeck M, Tryggvadottir L, Weiderpass E, Storm H. Avoidable cancers in the Nordic countries - the potential impact of increased physical activity on postmenopausal breast, colon and endometrial cancer. Eur J Cancer. 2019
Kenborg L, Winther JF, Linnet KM, Krøyer A, Albieri V, Holmqvist AS, Tryggvadottir L, Madanat-Harjuoja LM, Stovall M, Hasle H, Olsen JH; ALiCCS study group. Neurologic disorders in 4858 survivors of central nervous system tumors in childhood-an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study. Neuro Oncol. 2019
Michalek IM, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Pukkala E. Occupation and Risk of Kidney Cancer in Nordic Countries. Occup Environ Med. 2019.
Tryggvadóttir L. Krabbamein, áfengi og samfélagsleg ábyrgð [Cancer, alcohol and social responsibility]. Laeknabladid. 2019
Clausen CT, Hasle H, Holmqvist AS, Madanat-Harjuoja L, Tryggvadottir L, Wesenberg F, Bautz A, Winther JF, Licht SF. Hyperthyroidism as a late effect in childhood cancer survivors - an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study. Acta Oncol. 2019 Feb;58(2):227-231. doi: 10.1080/0284186X.2018.1535187. Epub 2018 Dec 26. PubMed PMID: 30585514.
Bonnesen TG, Asdahl PH, de Fine Licht S, Gudmundsdottir T, Holmqvist AS, Madanat-Harjuoja LM, Tryggvadottir L, Winther JF, Hasle AH; ALiCCS Study Group. Disease-specific Hospitalizations Among 5-Year Survivors of Hepatoblastoma: A Nordic Population-based Cohort Study. J Pediatr Hematol Oncol. 2019 Apr;41(3):181-186. doi: 10.1097/MPH.0000000000001378. PubMed PMID: 30557167.

Útgefið vísindaefni 2018

Maret-Ouda J, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries. JAMA Oncol. 2018 Nov 1;4(11):1576-1582. doi: 10.1001/jamaoncol.2018.3054. PubMed PMID: 30422249; PubMed Central PMCID: PMC6248086.
Thordardottir M, Lindqvist EK, Lund SH, Costello R, Burton D, Steingrimsdottir L, Korde N, Mailankody S, Eiriksdottir G, Launer LJ, Gudnason V, Harris TB, Landgren O, Torfadottir JE, Kristinsson SY. Dietary intake is associated with riskof multiple myeloma and its precursor disease. PLoS One. 2018 Nov 1;13(11):e0206047. doi: 10.1371/journal.pone.0206047. eCollection 2018. PubMed PMID: 30383820; PubMed Central PMCID: PMC6211667.
Hadkhale K, Martinsen JI, Weiderpass E, Kjærheim K, Sparén P, Tryggvadóttir L, Lynge E, Pukkala E. Occupational variation in bladder cancer in Nordic males adjusted with approximated smoking prevalence. Acta Oncol. 2018 Oct 15:1-9. doi: 10.1080/0284186X.2018.1518591. [Epub ahead of print] PubMed PMID: 30320536.
Michalek IM, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Pukkala E. Occupation and Risk of Kidney Cancer in Nordic Countries. J Occup Environ Med. 2018 Oct 10. doi: 10.1097/JOM.0000000000001468. [Epub ahead of print] PubMed PMID: 30308621.
Winther JF, Bhatia S, Cederkvist L, Gudmundsdottir T, Madanat-Harjuoja L, Tryggvadottir L, Wesenberg F, Hasle H, Sällfors Holmqvist A; ALiCCS Study Group. Risk of cardiovascular disease among Nordic childhood cancer survivors with diabetes mellitus: A report from adult life after childhood cancer in Scandinavia. Cancer. 2018 Oct 11. doi: 10.1002/cncr.31696. [Epub ahead of print] PubMed PMID: 30307617.
Stefansdottir V, Skirton H, Johannsson OT, Olafsdottir H, Olafsdottir GH, Tryggvadottir L, Jonsson JJ. Electronically ascertained extended pedigrees in breast cancer genetic counseling. Fam Cancer. 2018 Sep 24. doi: 10.1007/s10689-018-0105-3. [Epub ahead of print] PubMed PMID: 30251169.
Michalek IM, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Pukkala E. Occupation and risk of cancer of the renal pelvis in Nordic countries. BJU Int. 2018 Sep 14. doi: 10.1111/bju.14533. [Epub ahead of print] PubMed PMID: 30216629.
Katuwal S, Martinsen JI, Kjaerheim K, Sparen P, Tryggvadottir L, Lynge E, Weiderpass E, Pukkala E. Occupation and risk of cancer of the renal pelvis in Nordic countries. Cancer Causes Control. 2018 Aug 27.
Steliarova-Foucher E, Fidler MM, Colombet M, Lacour B, Kaatsch P, Piñeros M, Soerjomataram I, Bray F, Coebergh JW, Peris-Bonet R, Stiller CA; ACCIS contributors (including Tryggvadottir L). Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991-2010 (Automated Childhood Cancer Information System): a population-based study. Lancet Oncol. 2018 Sep;19(9):1159-1169. doi: 10.1016/S1470-2045(18)30423-6. Epub 2018 Aug 8. PubMed PMID: 30098952; PubMed Central PMCID: PMC6120055.
Talibov M, Sormunen J, Hansen J, Kjaerheim K, Martinsen JI, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E. Benzene exposure at workplace and risk of colorectal cancer in four Nordic countries. Cancer Epidemiol. 2018:55:156-161.
Norsker FN, Rechnitzer C, Cederkvist L, Tryggvadottir L, Madanat-Harjuoja LM, Øra I, Thorarinsdottir HK, Vettenranta K, Bautz A, Schrøder H, Hasle H, Winther JF. Somatic late effects in 5-year survivors of neuroblastoma: a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study. Int J Cancer. 2018 Jun 21.
Jonsdottir T, Valdimarsdottir H, Tryggvadottir L, Lund SH, Thordardottir M, Magnusson MK, Valdimarsdottir U. Viðhorf íslenskra kvenna til erfðaráðgjafar og erfðaprófa á BRCA1 og BRCA2 stökkbreytingum. [Views of Icelandic women towards genetic counseling - and testing of BRCA2 mutations]. Laeknabladid. 2018 Juni;104(6):289-296.
Kenborg L, Winther JF, Linnet KM, Krøyer A, Albieri V, Holmqvist AS, Tryggvadottir L, Madanat-Harjuoja LM, Stovall M, Hasle H, Olsen JH; ALiCCS study group. Neurologic Disorders in 4,858 Survivors of Central Nervous System Tumors in Childhood - an Adult Life after Cancer in Scandinavia (ALiCCS) study. Neuro Oncol. 2018 May 30.
Haraldsdottir A, Torfadottir JE, Valdimarsdottir UA, Adami HO, Aspelund T, Tryggvadottir L, Thordardottir M, Birgisdottir BE, Harris TB, Launer LJ, Gudnason V, Steingrimsdottir L. Dietary habits in adolescence and midlife and risk of breast cancer in older women. PLoS One. 2018 May 30;13(5)
Rafnar T, Sigurjonsdottir GR, Stacey SN, Halldorsson G, Sulem P, Pardo LM, Helgason H, Sigurdsson ST, Gudjonsson T, Tryggvadottir L, Olafsdottir GH, Jonasson JG, Alexiusdottir K, et al. Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin. J Natl Cancer Inst. 2018 May 14.
Andersson TM, Engholm G, Pukkala E, Stenbeck M, Tryggvadottir L, Storm H, Weiderpass E. Avoidable cancers in the Nordic countries-The impact of alcohol consumption. Eur J Cancer. 2018 May 5. pii: S0959-8049(18)30776-7.
Andersson TM, Engholm G, Brink AL, Pukkala E, Stenbeck M, Tryggvadottir L, Weiderpass E, Storm H. Tackling the tobacco epidemic in the Nordic countries and lower cancer incidence by 1/5 in a 30-year period-The effect of envisaged scenarios changing smoking prevalence. Eur J Cancer. 2018 Mar 29. pii: S0959-8049(18)30239-9.]
Nohlert E, Öhrvik J, Helgason ÁR. Self-perceived ability to cope with stress and depressive mood without smoking predicts successful smoking cessation 12 months later in a quitline setting: a secondary analysis of a randomized trial. BMC Public Health (2018) 18:1066 Doi.org/10.1186/s12889-018-5973-9
Isra B, Helgason ÁR. Using motivational interviewing to facilitate death talk in end-of-lifecare: an ethical analysis. BMC Palliative Care (2018) 17;51 Doi.org/10.1186/s12904-018-0305-5
Sacchetto L, Zanetti R, Comber H, Bouchardy C, Brewster DH, Broganelli P, Chirlaque MD, Coza D, Galceran J, Gavin A, Hackl M, Katalinic A, Larønningen S, Louwman MWJ, Morgan E, Robsahm TE, Sanchez MJ, Tryggvadóttir L, Tumino R, Van Eycken E, Vernon S, Zadnik V, Rosso S. Trends in incidence of thick, thin and in situ melanoma in Europe. Eur J Cancer. 2018 Mar;92:108-118.
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, Ogunbiyi OJ, Azevedo E Silva G, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP; CONCORD Working Group. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018 Mar 17;391(10125):1023-1075.
Talibov M, Pukkala E, Martinsen JI, Tryggvadottir L, Weiderpass E, Hansen J. Night-shift work and hematological cancers: a population based case-control study in three Nordic countries. Scand J Work Environ Health. 2018 May 1;44(3):258-264.
Pukkala, E., Engholm, G., Højsgaard Schmidt, L.K., Storm, H., Khan, S., Lambe, M., Pettersson, D., Ólafsdóttir, E., Tryggvadóttir, L., Hakanen, T., Malila, N., Virtanen, A., Johannesen, T.B., Larønningen, S., Ursin, G.: Nordic Cancer Registries - an overview of their procedures and data comparability. Acta Oncol. 2018; 57: 440-455.
Tao W, Artama M, von Euler-Chelpin M, Konings P, Ljung R, Lynge E, Ólafsdóttir GH, Pukkala E, Romundstad P, Tryggvadottir L, Wahlin K, Lagergren J. Data Resource Profile: The Nordic Obesity Surgery Cohort (NordOSCo). Int J Epidemiol. 2018 Feb 1;47(1):357. doi: 10.1093/ije/dyx256. PubMed PMID: 29190345.

Útgefið vísindaefni 2017

Asdahl PH, Ojha RP, Winther JF, Holmqvist AS, de Fine Licht S, Gudmundsdottir T, Madanat-Harjuoja L, Tryggvadottir L, Andersen KK, Hasle H; ALiCCS study group. Measuring childhood cancer late effects: evidence of a healthy survivor effect. Eur J Epidemiol. 2017 Dec;32(12):1089-1096. doi: 10.1007/s10654-017-0305-4. Epub 2017 Nov 28. PubMed PMID: 29185125.
Farioli A, Straif K, Brandi G, Curti S, Kjaerheim K, Martinsen JI, Sparen P, Tryggvadottir L, Weiderpass E, Biasco G, Violante FS, Mattioli S, Pukkala E. Occupational exposure to asbestos and risk of cholangiocarcinoma: a population-based case-control study in four Nordic countries. Occup Environ Med. 2017 Nov 13.
Barry KH, Martinsen JI, Alavanja MCR, Andreotti G, Blair A, Hansen J, Kjærheim K, Koutros S, Lynge E, Sparèn P, Tryggvadottir L, Weiderpass E, Berndt SI, Pukkala E. Risk of early-onset prostate cancer associated with occupation in the Nordic countries. Eur J Cancer. 2017 Nov 10;87:92-100.
Dickerman BA, Torfadottir JE, Valdimarsdottir UA, Wilson KM, Steingrimsdottir L, Aspelund T, Batista JL, Fall K, Giovannucci E, Sigurdardottir LG, Tryggvadottir L, Gudnason V, Markt SC, Mucci LA. Midlife metabolic factors and prostate cancer risk in later life. Int J Cancer. 2017 Nov 7.
Helgason ÁR. Karlsjúkdómalækningar. Læknablaðið (En. Icelandic Medical Journal). 2017, 11. tbl. 103.
Andersson TM, Weiderpass E, Engholm G, Lund AQ, Olafsdottir E, Pukkala E, Stenbeck M, Storm H. Corrigendum to "Avoidablecancer cases in the Nordic countries - The impact of overweight and obesity" [Eur J Cancer 79 (2017) 106-118]. Eur J Cancer. 2017 Dec;87:219-220. doi: 10.1016/j.ejca.2017.09.013. Epub 2017 Oct 10. No abstract available.
Tao W, Artama M, von Euler-Chelpin M, Konings P, Ljung R, Lynge E, Ólafsdóttir GH, Pukkala E, Romundstad P, Tryggvadottir L, Wahlin K, Lagergren J. Data Resource Profile: The Nordic Obesity Surgery Cohort (NordOSCo). Int J Epidemiol. 2017 Oct 1;46(5):1367-1367g.
Kjaer SK, Nygård M, Dillner J, Brooke Marshall J, Radley D, Li M, Munk C, Hansen BT, Sigurdardottir LG, Hortlund M, Tryggvadottir L, Joshi A, Das R, Saah AJ. A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries. Clin Infect Dis 2017 Oct 1.
Bonnesen TG, Winther JF, Andersen KK, Asdahl PH, de Fine Licht S, Gudmundsdottir T, Sällfors Holmqvist A, Madanat-Harjuoja LM, Tryggvadottir L, Wesenberg F, Heilmann C, Olsen JH, Hasle H; ALiCCS study group. Liver diseases in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): A population-based cohort study of 32,839 one-year survivors. Int J Cancer. 2017 Oct 11.
Siew SS, Martinsen JI, Kjaerheim K, Sparén P, Tryggvadottir L, Weiderpass E, Pukkala E. Occupational exposure to wood dust and risk of nasal and nasopharyngeal cancer: A case-control study among men in four Nordic countries-With an emphasis on nasal adenocarcinoma. Int J Cancer 2017;141(12):2430-2436.
Hadkhale K, MacLeod J, Demers PA, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Anne Harris M, Tjepkema M, Peters PA, Pukkala E. Occupational variation in incidence of bladder cancer: a comparison of population-representative cohorts from Nordic countries and Canada. BMJ Open. 2017;7(8):e016538.
Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C; CONCORD Working Group (including Tryggvadottir L). Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2). Gynecol Oncol. 2017 Feb;144(2):396-404. doi: 10.1016/j.ygyno.2016.11.019. Epub 2016 Dec 2. Erratum in: Gynecol Oncol. 2017 Dec;147(3):725. PubMed PMID: 27919574.
Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C; & the CONCORD Working Group (including Tryggvadottir L). The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2). Gynecol Oncol. 2017 Feb;144(2):405-413. doi: 10.1016/j.ygyno.2016.10.019. Epub 2016 Dec 6. Erratum in: Gynecol Oncol. 2017 Dec;147(3):726. PubMed PMID: 27931752.
Stefansson OA, Hermanowicz S, van der Horst J, Hilmarsdottir H, Staszczak Z, Jonasson JG, Tryggvadottir L, Gudjonsson T, Sigurdsson S. CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer. BMC Cancer. 2017;17(1):469.
Maret-Ouda J, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, Euler-Chelpin MV, Lagergren J. Cohort profile: the Nordic Antireflux Surgery Cohort (NordASCo). BMJ Open. 2017;7(6):e016505.
Talibov M, Auvinen A, Weiderpass E, Hansen J, Martinsen JI, Kjaerheim K, Tryggvadottir L, Pukkala E. Occupational solvent exposure and adult chronic lymphocytic leukemia: No risk in a population-based case-control study in four Nordic countries. Int J Cancer. 2017;141(6):1140-1147.
Tarvainen L, Suojanen J, Kyyronen P, Lindqvist C, Martinsen JI, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E. Occupational Risk for Oral Cancer in Nordic Countries. Anticancer Res. 2017 Jun;37(6):3221-3228.
de Fine Licht S, Rugbjerg K, Gudmundsdottir T, Bonnesen TG, Asdahl PH, Holmqvist AS, Madanat-Harjuoja L, Tryggvadottir L, Wesenberg F, Hasle H, Winther JF, Olsen JH; ALiCCS study group. Long-terminpatient disease burden in the Adult Life after Childhood Cancer inScandinavia (ALiCCS) study: A cohort study of 21,297 childhood cancer survivors. PLoS Med. 2017;14(5):e1002296.
Zink F, Stacey SN, Norddahl GL, Frigge ML, Magnusson OT, Jonsdottir I, Thorgeirsson TE, Sigurdsson A, Gudjonsson SA, Gudmundsson J, Jonasson JG, Tryggvadottir L, Jonsson T, Helgason A, Gylfason A, Sulem P, Rafnar T, Thorsteinsdottir U, Gudbjartsson DF, Masson G, Kong A, Stefansson K. Clonal hematopoiesis, with and without candidate driver mutations, iscommon in the elderly. Blood 2017 May 8. pii: blood-2017-02-769869. doi: 10.1182/blood-2017-02-769869. [Epub ahead of print]
Andersson TM, Weiderpass E, Engholm G, Lund AQ, Olafsdottir E, Pukkala E, Stenbeck M, Storm H. Avoidable cancer cases in theNordic countries - The impact of overweight and obesity. Eur J Cancer. 2017 Jul;79:106-118. doi: 10.1016/j.ejca.2017.03.028. Epub 2017 May 3.
Crujeiras AB, Díaz-Lagares A, Stefansson OA, Macias M, Sandoval J, Cueva J, López-López R, Moran S, Jonasson JG, Tryggvadottir L, Olafsdottir E, Tinahones FJ, Carreira MC, Casanueva FF, Esteller M. Obesity and menopause modify the epigenomic profile of breast cancer. Endocr Relat Cancer 2017 Apr 25. pii: ERC-16-0565. doi: 10.1530/ERC-16-0565. [Epub ahead of print]
Bonaventure A, Harewood R, Stiller CA, Gatta G, Clavel J, Stefan DC, Carreira H, Spika D, Marcos-Gragera R, Peris-Bonet R, Piñeros M, Sant M, Kuehni CE, Murphy MFG, Coleman MP, Allemani C; CONCORD Working Group. Worldwidecomparison of survival from childhood leukaemia for 1995-2009, by subtype, age,and sex (CONCORD-2): a population-based study of individual data for 89 828children from 198 registries in 53 countries. Lancet Haematol. 2017;4(5):e202-e217.
Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, Capocaccia R, Larrañaga N, Colonna M, Agius D, Ardanaz E, Rubió-Casadevall J, Kowalska A, Virdone S, Mallone S, Amash H, De Angelis R; EUROCARE-5 Working Group. Survival of 86,690 patients with thyroidcancer: A population-based study in 29 European countries from EUROCARE-5. Eur J Cancer 2017;77:140-152.
Kjartansdottir OJ, Sigurdardottir LG, Olafsdottir EJ, Jonasson JG, Ursin G, Tryggvadottir L. Estrogen-progestin use and breast cancer characteristics in lean and overweight postmenopausal women. Breast Cancer Res Treat. 2017;163(2):363-373.
Hadkhale K, Martinsen JI, Weiderpass E, Kjaerheim K, Sparen P, Tryggvadottir L, Lynge E, Pukkala E. Occupational exposure tosolvents and bladder cancer: A population-based case control study in Nordic countries. Int J Cancer. 2017;140(8):1736-1746.
Steliarova-Foucher E, Colombet M, Ries LAG et al. (Birgisson H as one of collaborators) International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol. 2017; 18(6): 719-731.

Útgefið vísindaefni 2016

de Fine Licht S, Rugbjerg K, Gudmundsdottir T, Bonnesen TG, Asdahl PH, Holmqvist AS, Madanat-Harjuoja L, Tryggvadottir L, Wesenberg F, Hasle H, Winther JF, Olsen JH; ALiCCS study group. Long-terminpatient disease burden in the Adult Life after Childhood Cancer inScandinavia (ALiCCS) study: A cohort study of 21,297 childhood cancer survivors. PLoS Med. 2017;14(5).
Zink F, Stacey SN, Norddahl GL, Frigge ML, Magnusson OT, Jonsdottir I, Thorgeirsson TE, Sigurdsson A, Gudjonsson SA, Gudmundsson J, Jonasson JG, Tryggvadottir L, Jonsson T, Helgason A, Gylfason A, Sulem P, Rafnar T, Thorsteinsdottir U, Gudbjartsson DF, Masson G, Kong A, Stefansson K. Clonal hematopoiesis, with and without candidate driver mutations, iscommon in the elderly. Blood 2017 May 8. pii: blood-2017-02-769869.
Crujeiras AB, Díaz-Lagares A, Stefansson OA, Macias M, Sandoval J, Cueva J, López-López R, Moran S, Jonasson JG, Tryggvadottir L, Olafsdottir E, Tinahones FJ, Carreira MC, Casanueva FF, Esteller M. Obesityand menopause modify the epigenomic profile of breast cancer. Endocr Relat Cancer 2017 Apr 25. pii: ERC-16-0565. doi: 10.1530/ERC-16-0565. [Epub ahead of print]
Bonaventure A, Harewood R, Stiller CA, Gatta G, Clavel J, Stefan DC, Carreira H, Spika D, Marcos-Gragera R, Peris-Bonet R, Piñeros M, Sant M, Kuehni CE, Murphy MFG, Coleman MP, Allemani C; CONCORD Working Group. Worldwidecomparison of survival from childhood leukaemia for 1995-2009, by subtype, age,and sex (CONCORD-2): a population-based study of individual data for 89 828children from 198 registries in 53 countries. Lancet Haematol. 2017;4(5):e202-e217.
Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, Capocaccia R, Larrañaga N, Colonna M, Agius D, Ardanaz E, Rubió-Casadevall J, Kowalska A, Virdone S, Mallone S, Amash H, De Angelis R; EUROCARE-5 Working Group. Survival of 86,690 patients with thyroidcancer: A population-based study in 29 European countries from EUROCARE-5. Eur J Cancer 2017;77:140-152.
Kjartansdottir OJ, Sigurdardottir LG, Olafsdottir EJ, Jonasson JG, Ursin G, Tryggvadottir L. Estrogen-progestin use andbreast cancer characteristics in lean and overweight postmenopausal women. Breast Cancer Res Treat. 2017;163(2):363-373.
Hadkhale K, Martinsen JI, Weiderpass E, Kjaerheim K, Sparen P, Tryggvadottir L, Lynge E, Pukkala E. Occupational exposure tosolvents and bladder cancer: A population-based case control study in Nordiccountries. Int J Cancer. 2017;140(8):1736-1746.
Benonisdottir S, Oddsson A, Helgason A, Kristjansson RP, Sveinbjornsson G, Oskarsdottir A, Thorleifsson G, Davidsson OB, Arnadottir GA, Sulem G, Jensson BO, Holm H, Alexandersson KF, Tryggvadottir L, Walters GB, Gudjonsson SA, Ward LD, Sigurdsson JK, Iordache PD, Frigge ML, Rafnar T, Kong A, Masson G, Helgason H, Thorsteinsdottir U, Gudbjartsson DF, Sulem P, Stefansson K. Epigenetic and genetic components of height regulation. Nat Commun. 2016 Nov 16;7:13490.
Haraldsdottir A, Steingrimsdottir L, Valdimarsdottir U, Aspelund T, Tryggvadottir L, Harris TB, Launer L, Mucci LA, Giovannucci EL, Adami HO, Gudnason V, Torfadottir JE. Early life residence, fishconsumption and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2016 Oct 10. pii: cebp.0473.2016. [Epub ahead of print]
Jonasson JG, Stefansson OA, Johannsson OT, Sigurdsson H, Agnarsson BA, Olafsdottir GH, Alexiusdottir KK, Stefansdottir H, Munoz Mitev R, Olafsdottir K, Olafsdottir K, Arason A, Stefansdottir V, Olafsdottir EJ, Barkardottir RB, Eyfjord JE, Narod SA, Tryggvadóttir L. Oestrogenreceptor status, treatment and breast cancer prognosis in Icelandic BRCA2mutation carriers. Br J Cancer. 2016; 115(7):776-83.
Sormunen J, Talibov M, Martinsen JI, Kjaerheim K, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E. Perceived physicalstrain at work and incidence of colorectal cancer: A nested case-control study. Cancer Epidemiol. 2016 Aug;43:100-4.
Bonnesen TG, Winther JF, Asdahl PH, de Fine Licht S, Gudmundsdottir T, Sällfors Holmqvist A, Madanat-Harjuoja LM, Tryggvadottir L, Wesenberg F, Birn H, Olsen JH, Hasle H; ALiCCS study group. Long-term risk of renal and urinary tract diseases in childhood cancer survivors: Apopulation-based cohort study. Eur J Cancer. 2016 Sep;64:52-61.
Hadkhale K, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Pukkala E. Occupation and Risk of Bladder Cancer in Nordic Countries. J Occup Environ Med. 2016 Jun 10.
Alfonso JH, Martinsen JI, Pukkala E, Weiderpass E, Tryggvadottir L, Nordby KC, Kjærheim K. Occupation and relative risk of cutaneoussquamous cell carcinoma (cSCC): A 45-year follow-up study in 4 Nordic countries. J Am Acad Dermatol. 2016 Jun 1.
Asdahl PH, Winther JF, Bonnesen TG, De Fine Licht S, Gudmundsdottir T, Holmqvist AS, Malila N, Tryggvadottir L, Wesenberg F, Dahlerup JF, Olsen JH, Hasle H; ALiCCS study group. Gastrointestinal andliver disease in Adult Life After Childhood Cancer in Scandinavia: Apopulation-based cohort study. Int J Cancer. 2016 Oct 1;139(7):1501-11.
Bryk S, Pukkala E, Martinsen JI, Unkila-Kallio L, Tryggvadottir L, Sparén P, Kjaerheim K, Weiderpass E, Riska A. Incidence andoccupational variation of ovarian granulosa cell tumours in Finland, Iceland,Norway and Sweden during 1953-2012: a longitudinal cohort study. BJOG. 2016 Feb 29. doi: 10.1111/1471-0528.13949.
Thorgeirsson T, Jordahl KM, Flavin R, Epstein MM, Fiorentino M, Andersson SO, Andren O, Rider JR, Mosquera JM, Ingoldsby H, Fall K, Tryggvadottir L, Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToPCaP). Intracellular location of BRCA2 protein expression andprostate cancer progression in the Swedish Watchful Waiting Cohort. Carcinogenesis 2016;37(3):262-8.
Stacey SN, … Tryggvadottir L, … Kiemeney LA, Thorleifsson G, Stefansson K. Insertion of an SVA-E retrotransposon into theCASP8 gene is associated with protection against prostate cancer. Hum Mol Genet. 2016 Jan 5. pii: ddv622. [Epub ahead of print]
Hjalgrim LL, Rostgaard K, Engholm G, Pukkala E, Johannesen TB, Ólafsdóttir E, Hjalgrim H. Aetiologicheterogeneity in pediatric Hodgkin lymphoma? Evidence from the Nordic countries, 1978-2010. Acta Oncol. 2016;55(1):85-90. doi: 10.3109/0284186X.2015.1049660. Epub 2015 Jun 13.

Útgefið vísindaefni 2015

Thorgeirsson T, Jordahl KM, Flavin R, Epstein MM, Fiorentino M, Andersson SO, Andren O, Rider JR, Mosquera JM, Ingoldsby H, Fall K, Tryggvadottir L, Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToPCaP). Intracellular location of BRCA2 protein expression and prostate cancer progression in the Swedish Watchful Waiting Cohort . Carcinogenesis. 2016 Jan 16. pii: bgw001.
Stacey SN, … Jonasson JG, Tryggvadottir L, … Kiemeney LA, Thorleifsson G, Stefansson K. Insertion of an SVA-E retrotransposon into the CASP8 gene is associated with protection against prostate cancer . Hum Mol Genet. 2016 Jan 5. pii: ddv622.
Stefansson H, Sigurgeirsson B, Olafsson JH, Olafsdottir E, Mooney E, Tryggvadottir L, Jonasson JG. Cutaneous melanoma in Iceland: changingBreslow's tumour thickness. JEADV 2015; 29:346-352.
Stefansson OA, Moran S, Gomes A, Sayols S. Arribas-Jorba C, Sanoval J, Hilmarsdottir H, Olafsdottir E, Tryggvadottir L, Jonasson JG, Eyfjord JE, Esteller M. ADNA methylation-based definition of biologically distinct breast cancersubtypes . Molecular Oncology 2015; 9:555-568.
Axelsson TA, Hrafnkelsson J, Olafsdottir EJ, Jonasson JG. Tall cell variant of papillarythyroid carcinoma: A population based study in Iceland . Thyroid 2015: 25(2):216-220.
Joensuu H, Rutkowski, Nishida T, Steigen SE, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C, Bordoni A, Magnusson MK, Suffliarsky J, Massimo F, Jonasson JG and Emile F. KIT and PDGFRA mutations and the riskof gastrointestinal stromal tumor recurrence . J Clin Oncol 2015; 33(6):634-642.
Gudbjartsson DF, Helgason H, Gudjonsson SA, Zink F, Gylfason A, .. Jonasson JG et al.. Large-scalewhole-genome sequencing of the Icelandic population . Nature Genetics 2015 03/2015; DOI:10.1038/ng.3247.
Stacey S, Helgason H, Gudjonsson SA, Thorleifsson G, Zink F, .. Jonasson JG, Tryggvadottir L et al.. New Basal Cell Carcinoma Susceptibility Loci . Nature Communications 2015 DOI: 10.1038/ncomms7825.
Rubio CA, Jonasson JG. Two Phenotypes of Traditional Serrated Adenomas NationwideSurvey in Iceland . Anticancer Research 2015 Sep,35(9):4929-33.
Agustsson TTh, Baldvinsdottir T, Jonasson JG, Olafsdottir E, Steinthorsdottir V, Sigurdsson G, Thorsson AV, Carroll PV, Korbonits M, Benediktsson R. The Epidemiology of Pituitary Adenomas in Iceland 1955-2012 : A Nationwide Population based Study. Eur J Endocrinol 2015; 173(5): 655-664.
Rossi S, Baili P, Caldora M, Carrani E, Minicozzi P, Pierannunzio D, Santaquilani M, Trama A, Allemani C, Aurelian B, Lorz M, Capocaccia R, De Angelis R, and the EUROCARE-5 Working Group (…Jonasson JG, Tryggvadottir LT…). The EUROCARE-5 study on cancer survival in Europe1999-2007: Database, quality checks and statistical analysis methods . Eur J Cancer 2015; 51: 2104-2119.
Baili P, Di Salvo F, Marcos-Gragera R, Siesling S, Mallone S, Santaquilani M, Micheli A, Lillini R, Francisci S and the EUROCARE-5 Working Group (…Jonasson JG, Tryggvadottir LT…). Age and case mix-standardized survival forall cancer patients in Europe 1999-2007: Results of EUROCARE-5, apopulation-based study . Eur J Cancer 2015; 51: 2120-2129.
Gatta G, Botta L, Sánchez MJ, Anderson LA, Licitra L, and the EUROCARE-5 Working Group (…Jonasson JG, Tryggvadottir LT…). Prognoses and improvement for head and neckcancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-basedstudy. Eur J Cancer 2015; 51: 2130-2143.
Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, Holleczek B, Johnston BT, Cook MB, Bannon F, Sant M and Eurocare-5 Working Group (…Jonasson JG, Tryggvadottir LT…). Survival for oesophageal, stomach and smallintestine cancers in Europe 1999-2007: Results from EUROCARE-5 . Eur J Cancer 2015; 51: 2144-2157.
Holleczek B, Rossi S, Domenic A, Innos K, Minicozzi P, Francisci S, Hackl M, Eisemann N, Brenner H and EUROCARE-5 Working group (…Jonasson JG, Tryggvadottir LT…). On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999-2007 – Results from the EUROCARE-5 study . Eur J Cancer 2015; 51: 2158-2168.
Lepage C, Capocaccia R, Hackl M, Lemmens V, Molina E, Pierannunzio M, Sant M, Trama A, Faivre J and the EUROCARE-5 Working Group (…Jonasson JG, Tryggvadottir LT…). Survival in patients with primary liver cancer, gallbladder andextrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007:Results of EUROCARE-5. Eur J Cancer 2015; 51: 2169-2178.
Crocetti E, Mallone S, Robsaham TE, Anna G, Domenic A, Eva AAM, Dolores CLM, Kaire I, Minicozzi P, Lorenzo B, Pierannunzio D, Eisemann N and the EUROCARE-5 Working Group (…Jonasson JG, Tryggvadottir LT…). Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study . Eur J Cancer 2015; 51: 2179-2190.
Sant M, Minicozzi P, Agresti R, Holleczek B, Bielska-Lasota M, Lopez MDC, Dimitrova N, Innos K, Katalinic A, Langseth H, Larranaga N, Rossi R, Pérez MJS, Siesling S and the EUROCARE-5 Working Group (…Jonasson JG, Tryggvadottir LT…). Survival of women with cancers of the breastand genital organs in Europe 1999-2007: Results of the EUROCARE-5 study. Eur J Cancer 2015; 51: 2191-2205.
Trama A, Foschi R, Larranaga N, Nicolai N, Sant M, Serraino D, Tavilla A, van Eycken L and the EUROCARE-5 Working Group (…Jonasson JG, Tryggvadottir LT…). S urvival of male genital cancers (prostate, testis andpenis) in Europe 1999-2007: Results from the EUROCARE-5 study . Eur J Cancer 2015; 51: 2206-2216.
Marcos-Gragera R, Mallone S, Kiemeney LA, Vilardell L, Malats N, Alloy Y, Sant M and the EUROCARE-5 Working group (…Jonasson JG, Tryggvadottir LT…). Urinary tract cancersurvival in Europe 1999-2007: Results of the population-based studyEUROCARE-5 . Eur J Cancer 2015; 51: 2217-2230.
Visser O, Aicua A, Botta L, Sant M, Tvailla A, Minicozzi P and the EUROCARE-5 Working Group (…Jonasson JG, Tryggvadottir LT…). Survival of adults with primary malignantbrain tumours in Europe; Results of the EUROCARE-5 study . Eur J Cancer 2015; 51: 2231-2241.
Francisci S, Ardanaz E, Grimsrud TK, Knijn A, Minicozzi P, Pastorini U, Pierannunzio D, Martinez DS, Sant M, Trama A and the EUROCARE-5 Working Group (…Jonasson JG, Tryggvadottir LT…). Survival patterns in lung and pleura cancer in Europe 1999-2007: Results from the EUROCARE-5study . Eur J Cancer 2015; 51: 2242-2253.
De Angelis R, Minicozzi P, Agius D, Maso LD, Marcos-Gragera R, Maynadié M, Meneghini E, Monnereau A, Osca-Gelis G, Poazzi P, Sant M, Trussard X, Visser O and the EUROCARE-5 Working Group (…Jonasson JG, Tryggvadottir LT…). Survival variations by country and age for lymphoid andmyeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 populationbased study . Eur J Cancer 2015; 51: 2254-2268.
Kristinsdóttir SM, Mariusdottir E, Jonasson JG, Steingrimsson E, Gudbjartsson T. Tilfelli mánaðarins. Kona á níræðisaldri með mæði og surg við öndun . Læknablaðið (Icelandic Med J) 2015; 101: 457-459.
Baldvinsdottir B, Jonasson JG, Hilmarsson R. Solitary retroperitoneal ganglioneuroma . Cogent Medicine 2015: 2; DOI.10.1080/2331205X.2015.1115705.
Holmqvist AS, Olsen JH, Mellemkjaer L, Garwicz S, Hjorth L, Moëll C, Månsson B, Tryggvadottir L, Hasle H, Winther JF; ALiCCS study group. Autoimmune diseases in Adult Lifeafter Childhood Cancer in Scandinavia (ALiCCS) . Ann Rheum Dis. 2015 Nov 10. pii: annrheumdis-2015-207659.
Fallah M, Kharazmi E, Pukkala E, Tretli S, Olsen JH, Tryggvadottir L, Sundquist K, Hemminki K. Familial risk of non-Hodgkin lymphoma by sex, relationship, age atdiagnosis and histology: a joint study from five Nordic countries . Leukemia. 2015 Oct 6. doi: 10.1038/leu.2015.272. [Epub ahead of print]
Day FR, Ruth KS, Thompson DJ, …Tryggvadottir L et al.. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair . Nat Genet. 2015 Nov;47(11):1294-303.
Hrafnkelsdóttir SM, Torfadóttir JE, Aspelund T, Magnusson KT, Tryggvadóttir L, Gudnason V, Mucci LA, Stampfer M, Valdimarsdóttir UA. Physical Activity from Early Adulthood and Risk of Prostate Cancer: A 24-Year Follow-Up Study among Icelandic Men. Cancer Prev Res (Phila). 2015 Oct;8(10):905-11.
Kharazmi E, Fallah M, Pukkala E, Olsen JH, Tryggvadottir L, Sundquist K, Tretli S, Hemminki K. Risk of familial classical Hodgkin lymphoma by relationship, histology, age, and sex: a joint study from five Nordic countries . Blood. 2015;126(17):1990-5.
Asdahl PH, Winther JF, Bonnesen TG, De Fine Licht S, Gudmundsdottir T, Anderson H, Madanat-Harjuoja L, Tryggvadottir L, Småstuen MC, Holmqvist AS, Hasle H, Olsen JH; ALiCCS Study Group. The adult life after childhood cancer in scandinavia (ALiCCS) study: Design and characteristics. Pediatr Blood Cancer. 2015 Jul 20. doi: 10.1002/pbc.25661.
Helgason H, Rafnar T, Olafsdottir HS, Jonasson JG, Sigurdsson A, Stacey SN, Jonasdottir A, Tryggvadottir L et al.. Loss-of-function variants in ATM confer risk of gastric cancer . Nat Genet. 2015;47(8):906-10.
Nygård M, Saah A, Munk C, Tryggvadottir L, Enerly E, Hortlund M, Sigurdardottir LG, Vuocolo S, Kjaer SK, Dillner J. Evaluation of the Long-Term Anti-Human Papillomavirus 6 (HPV6), 11, 16, and 18 Immune Responses Generated by the Quadrivalent HPV Vaccine . Clin Vaccine Immunol. 2015;22(8):943-8.
Talibov M, Guxens M, Pukkala E, Huss A, Kromhout H, Slottje P, Martinsen JI, Kjaerheim K, Sparén P, Weiderpass E, Tryggvadottir L, Uuksulainen S, Vermeulen R. Occupational exposure to extremely low-frequency magnetic fields and electrical shocks and acute myeloid leukemia in four Nordic countries . Cancer Causes Control. 2015 Aug;26(8):1079-85.
Kharazmi E, Hemminki K, Pukkala E, Sundquist K, Tryggvadottir L, Tretli S, Olsen JH, Fallah M. Cancer Risk in Relatives of Testicular Cancer Patients by Histology Type and Age at Diagnosis: A Joint Study from Five Nordic Countries . Eur Urol. 2015 Aug;68(2):283-9.
Winther JF, Kenborg L, Byrne J, Hjorth L, Kaatsch P, Kremer LC, Kuehni CE, Auquier P, Michel G, de Vathaire F, Haupt R, Skinner R, Madanat-Harjuoja LM, Tryggvadottir L et al.. Childhood cancer survivor cohorts in Europe . Acta Oncol 2015;54(5):655-68.
Gudmundsdottir T, F Winther J, de Fine Licht S, G Bonnesen T, H Asdahl P, Tryggvadottir L, Anderson H, Wesenberg F, Malila N, Hasle H, H Olsen J; ALiCCS study group. Cardiovascular disease in Adult Life after Childhood Cancer in Scandinavia: A population-based cohort study of 32,308 one-year survivors . Int J Cancer. 2015 Feb 3
Reijula J, Kjaerheim K, Lynge E, Martinsen JI, Reijula K, Sparén P, Tryggvadottir L, Weiderpass E, Pukkala E. Cancer incidence among waiters: 45 years of follow-up in five Nordic countries . Scand J Public Health. 2015 Jan 6. pii: 1403494814565130.

Útgefið vísindaefni 2014

Alexandersson BT, Hreinsson JP, Stefansson T, Jonasson JG, Bjornsson ES. The risk of colorectal cancer after an attack of uncomplicated diverticulitis . Scand J Gastroenterology 2014: 49(5); 576-580.
Aradottir M, Reynisdottir ST, Stefansson OA, Jonasson JG, Sverrisdottir A, Tryggvadottir L, Eyfjord JE, Bodvarsdottir SK. Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers . Jl Pathol: Clin Res 2014: I: 33-40.
Axelsson TA, Hrafnkelsson J, Olafsdottir EJ, Jonasson JG. Tall cell variant of papillary thyroid carcinoma: A population based study in Iceland . Thyroid 2014: Doi: 10.1089/thy.2014.0075.
Baldvinsdottir B, Jonasson JG, Agnarsson UP, Sigurjonsdottir HA. Ectopic Cushing Syndrome Due to Colon Cancer With Dual Morphology. J Endocrinol Metabol 2014; 4(5-6): 153-154.
Cooke SL, Shlien A, Marshall J, Pipinikas CP, Martincorena I, Tubio JMC, …, ICGC Breast Cancer Group (... Jonasson JGJ ...) et al.. Processed pseudogenes acquired somatically during cancer development . Nature Communications 2014: 5:3644/DOI: 10.1038/ncomms4644.
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, …; EUROCARE-5 Working Group (... Jonasson JG, Tryggvadottir LT....). Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study . Lancet Oncol. 2014 Jan;15(1):23-34.
de Fine Licht S, Winther JF, Gudmundsdottir T, Holmqvist AS, Bonnesen TG, Asdahl PH, Tryggvadottir L, et al.; on behalf of the ALiCCS study group. Hospital contacts for endocrine disorders in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): a population-based cohort study . Lancet. 2014 Feb 17.
Fallah M, Pukkala E, Sundquist K, Tretli S, Olsen JH, Tryggvadottir L, Hemminki K. Familial melanoma by histology and age: Joint data from five Nordic countries. Eur J Cancer. 2014 Jan 21.
Gatta G, Botta L, Rossi S, Aereleid T, Bielska-Lasota M,Clavel J, Dimitrova N, … and the Eurocare Working Group (... Jonasson JG, Tryggvadottir LT....). Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5 – a population-based study . Lancet Oncol. 2014; 15: 35-47.
Holmqvist AS, Olsen JH, Andersen KK, Licht SD, Hjorth L, Garwicz S, Moëll C, Anderson H, Wesenberg F, Tryggvadottir L et al.; on behalf of the ALiCCS study group. Adult Life after Childhood Cancer in Scandinavia: Diabetes mellitus following treatment for cancer in childhood. Eur J Cancer. 2014 Feb 4.
Hreinsson JP, Jonasson JG, Bjornsson ES. Bleeding-related symptoms in colorectal cancer: A 4-year nationwide population-based study. Alimentary Pharmacology and Therapeutics 2014: 39(1); 77-84.
Laufey Tryggvadóttir. Saga og þróun Krabbameinsfélags Íslands. Læknablaðið 10. tbl. 100. árg. 2014.
Nygård M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, Hortlund M, Liaw KL, Dasbach EJ, Kjær SK. Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance. PLoS One. 2014 Feb 5;9(2).
Oddsson K, Briem H, Gudmundsdottir Th. National survey among parents or guardians of 12 year old Icelandic girls to assess attitude regarding HPV vaccination and knowledge about cervical cancer. Submitted for publication, Scandinavian Journal of Primary Health Care.
Pukkala E, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Tryggvadottir L, Sparén P, Demers PA. Cancer incidence among firefighters: 45 years of follow-up in five Nordic countries. Occup Environ Med. 2014 Feb 6. doi: 10.1136/oemed-2013-101803. [Epub ahead of print].
Sant M, Minicozzi P, Mounier M, Anderson LA, De Angelis R, Maynadié M, Monnereau A, Marcos-Gragera R, Visser O and the Eurocare Working group (....Jonasson JG.....). Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based stud . Lancet Oncol. 2014 Aug;15(9):931-42.
Snaebjornsson P, Coupe VMH, Jonasson L, van Grieken NC, Meijer GA, Jonasson JG. pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited. Int J Cancer 2014: 135(2); 467-478.
Stefansson H, Sigurgeirsson B, Olafsson JH, Olafsdottir E, Mooney E, Tryggvadottir L, Jonasson JG. Trends in Breslow's tumour thickness of cutneous melanoma in Iceland 1980-2009. JEADV 2014;29(2):346-52.
Stefansson OA, Moran S, Gomes A, Sayols S. Arribas-Jorba C, Sanoval J, Hilmarsdottir H, Olafsdottir E, Tryggvadottir L, Jonasson JG, Eyfjord JE, Esteller M. A DNA methylation-based definition of biologically distinct breast cancer subtypes. Molecular Oncology 11/2014 DOI: 101016/j.molonc 2014.10012.
Talibov M, Lehtinen-Jacks S, Martinsen JI, Kjærheim K, Lynge E, Sparén P, Tryggvadottir L, Weiderpass E, Kauppinen T, Kyyrönen P, Pukkala E. Occupational exposure to solvents and acute myeloid leukemia: a population-based, case-control study in four Nordic countries. Scand J Work Environ Health. 2014 May 19.
Thorbjarnardottir T, Olafsdottir EJ, Valdimarsdottir UA, Olafsson O, Tryggvadottir L. Oral contraceptives, hormone replacement therapy and breast cancer risk: A cohort study of 16 928 women 48 years and older. Acta Oncol. 2014 Jan 24. [Epub ahead of print].
Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, .., The Eurocare-5 Working Group (... Tryggvadottir L, Jonasson JG....). Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 – a population-based study. Lancet Oncol. 2014; 15: 23-34.
Zanetti R, Schmidtmann I, Sacchetto L, Binder-Foucard F, Bordoni A, .. Tryggvadottir L et al.. Completeness and timeliness: Cancer registries could/should improve their performance. Eur J Cancer. 2014 Jan 3

Útgefið vísindaefni 2013

Alexiusdottir KK, Möller PH, Snaebjornsson P, Jonasson L, Olafsdottir EJ, Bjornsson ES, Tryggvadottir L, Jonasson JG. Colon Cancer: Association of Histopathological Parameters and Patients' Survival with Clinical Presentation. APMIS 2013: 121(10); 901-907 (DOI 10.1111/apm.12109).
Arnold M, Holterhues C, Hollestein LM, Coebergh JW, Nijsten T, Pukkala E, Holleczek B, Tryggvadóttir L, Comber H, Bento MJ, Diba CS, Micallef R, Primic-Žakelj M, Izarzugaza MI, Perucha J, Marcos-Gragera R, Galceran J, Ardanaz E, Schaffar R, Pring A, de Vr Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J Eur Acad Dermatol Venereol. 2013 Aug 21.
Bjornsson ES, Jonasson JG. Drug-induced cholestasis. Clin Liver Dis 2013: May;17(2):191-209. Doi: 10.1016/j.cld.2012.11.002. Epub 2012 Dec 20.
Brasso K, Ingimarsdóttir IJ, Rusch E, Engholm G, Adolfsson J, Tryggvadóttir L, Jónsson E, Bill-Axelson A, Holmberg E, Storm HH. Differences in survival from prostate cancer in Denmark, Iceland and Sweden. Eur J Cancer. 2013 May;49(8):1984-92.
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R, The Eurocare-5 Working Group (... Jonasson JG....). Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 – a population-based study. Lancet Oncol. Birt online 5. Desember 2013: dx.doi.org/10.1016/S1470-2045(13)70546-1; bls 1-12 + suppl. online.
Fallah M, Pukkala E, Tryggvadottir L, Olsen JH, Tretli S, Sundquist K, Hemminki K. Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. J Med Genet. 2013 Jun;50(6):373-82.
Gatta G, Botta L, Rossi S, Aereleid T, Bielska-Lasota M,Clavel J, Dimitrova N, Jakob Z, Kaatsch P, Lacour B, Mallone S, Marcos_Gragera R, Minicozzi P, Sánchez-Pérez M-J, Sant M, Santaquilani M, Stiller C, Tavilla A, Trama A, Visser O, Peris-Bonet R, ant t Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5 – a population-based study. Lancet Oncol. Birt online 5. Desember 2013: dx.doi.org/10.1016/S1470-2045(13)70548-5; bls 1-13 + suppl. online
Gunnarsdottir HK, Vidarsdottir H, Rafnsdottir GL, Tryggvadottir L, Olafsdottir EJ, Lindbohm ML. Employment participation and work experience of male cancer survivors: A NOCWO study. Work. 2013 Sep 4.
Styrkarsdottir U, Thorleifsson G, Gudbjartsson D, Sulem P, Sigurdsson A, Jonasdottir A, Jonasdottir A, Oddsson A, Helgason A, Magnusson OT, Walters GB, Frigge ML, Helgadottir HT, Johannsdottir H, Bergsteinsdottir K, Ogmundsdottir MH, Center JR, Nguyen T VNonsense mutation in the LGR4 gene associates with several human diseases and other traits. Nature 2013; 597, May: 517-520.
Torfadottir JE, Valdimarsdottir UA, Mucci LA, Kasperzyk JL, Fall K, Tryggvadottir L, Aspelund T, Olafsson O, Harris TB, Jonsson E, Tulinius H, Gudnason V, Adami HO, Stampfer M, Steingrimsdottir L. Consumption of Fish Products across the Lifespan and Prostate Cancer Risk. PLoS One. 2013 Apr 17;8(4):e59799.
Tryggvadottir L, Olafsdottir EJ, Olafsdottir GH, Sigurdsson H, Johannsson OT, Stefansson OA, Agnarsson BA, Eyfjord J, Jonasson JG. Tumour Diploidy and Survival in Breast Cancer Patients with BRCA2 mutation. Breast Cancer Research and Treatment 2013: 140(2); 375-384 (DOI 10.1007/s10549-013-2637-4).
Vlaanderen J, Straif K, Martinsen JI, Kauppinen T, Pukkala E, Sparén P, Tryggvadottir L, Weiderpass E, Kjaerheim K. Cholangiocarcinoma among workers in the printing industry: using the NOCCA database to elucidate the generalisability of a cluster report from Japan. Occup Environ Med. 2013 Dec;70(12):828-30.
Vlaanderen J, Straif K, Pukkala E, Kauppinen T, Kyyrönen P, Martinsen JI, Kjaerheim K, Tryggvadottir L, Hansen J, Sparén P, Weiderpass E. Occupational exposure to trichloroethylene and perchloroethylene and the risk of lymphoma, liver, and kidney cancer in four Nordic countries. Occup Environ Med. 2013 Jun;70(6):393-401.

Útgefið vísindaefni 2012

Alexiusdottir KK, Möller PH, Snaebjornsson P, Jonasson L, Olafsdottir EJ, Björnsson ES, Tryggvadottir L, Jonasson JG. Association of symptoms of colon cancer patients with tumor location and TNM tumor stage. Scand J Gastroenterol. 2012 Apr 17.
Allemani C, Sant M, Weir HK, Tryggvadottir L, Tumino R, Velten M, Vercelli M, Wolf HJ, Woronoff AS, Wu X, Coleman MP. Breast cancer survival in the US and Europe: A CONCORD high-resolution study. Int J Cancer 2012 Jul 20. doi: 10.1002/ijc.27725.
Baldursdottir TR, Bergmann OM, Jonasson JG, Ludviksson BR, Axelsson TA, Bjornsson ES. The incidence, prevalence and the natural history of primary biliary cirrhosis: a nationwide population based study from Iceland. Eur J Gastroenterology and Hepatology 2012: 24 (7): 824-830.
Bergmann OB, Kristjansson G, Jonasson JG, Bjornsson ES. Jaundice due to suspected statin hepatotoxicity: a case series. Digestive Diseases and Sciences 2012; 57 (7): 1959-1964.
Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Masson G, He H, Jonasdottir A, Sigurdsson A, Stacey SN, Johannsdottir H, Helgadottir HT, Li W, Nagy R, Ringel MD, Kloos RT, de Visser MC, Plantinga TS, den Heijer M, Aguillo E, Panadero A, Prats E, Gar Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet. 2012 Jan 22. doi: 10.1038/ng.1046.
Gudmundsson J, Sulem P, Gudbjartsson DF, Masson G, Agnarsson BA, Benediktsdottir KR, Sigurdsson A, Magnusson OT, Gudjonsson SA, Magnusdottir DN, Johannsdottir H, Helgadottir HT, Stacey SN, Jonasdottir A, Olafsdottir SB, Thorleifsson G, Jonasson JG, Tryggv A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer. Nat Genet. 2012 Oct 28. doi: 10.1038/ng.2437.
Joensuu H, Vehtari A, Riihimäki J, Nishida T, Eriksson SS, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C, Bordoni A, Magnusson M, Linke Z, Suffliarsky J, Massimo F, Jonasson JG, Dei Tos AP, Rutkowski P. Risk of gastrointestinal stromal tumour recurrence after surgery: an analysis based on pooled population-based cohorts. Lancet Oncology 2012; 13 (3): 265-274.
Jonsdottir AB, Stefansson OA, Bjornsson J, Jonasson JG, Ogmundsdottir HM, Eyfjord JE. Tetraploidy in BRCA2 breast tumours. Eur J Cancer 2012; 48 (3): 305-310
Koivisto-Korander R, Scélo G, Ferro G, Mellemkjaer L, Hemminki K, Weiderpass E, Tamaro S, Pompe-Kirn V, Tracey E, Brewster DH, Kliewer EV, Tonita JM, Kee-Seng C, Jonasson JG, Martos C, Brennan P, Straif K, Pukkala E. Second primary malignancies among women with uterine sarcoma. Gynaecologic Oncology 2012; 126 (1): 30-35.
Rubio CA, Kristjansdottir, Thodleifsson B, Olafsdottir E, Jonasson JG. The frequency of advanced adenoma in consulting patients. A nationwide survey in Iceland (2003-2006). Colorectal Disease 2012; 14 (9): e595-e602.
Sigurdardottir LG, Jonasson JG, Stefansdottir S, Jonsdottir A, Olafsdottir GH, Olafsdottir EJ, Tryggvadottir L. Data quality at the Icelandic Cancer Registry: Comparability, validity, timeliness and completeness. Acta Oncol. 2012 Sep;51(7):880-9.
Stefansdottir V, Johannsson OT, Skirton H, Tryggvadottir L, Tulinius H, Jonsson JJ. The use of genealogy databases for risk assessment in genetic health service: asystematic review. J Community Genet. 2012 Jul 18.
Stolk L, Perry JR, Chasman DI, He C, Mangino M, Sulem P, Barbalic M, Broer L, Byrne EM, Ernst F, Esko T, Franceschini N, Gudbjartsson DF, Hottenga JJ, Kraft P, McArdle PF, Porcu E, Shin SY, Smith AV, van Wingerden S, Zhai G, Zhuang WV, Albrecht E, AlizadeMeta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet. 2012 Jan 22. doi: 10.1038/ng.1051. [Epub ahead of print]
Talibov M, Kautiainen S, Martinsen JI, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E. Occupation and Leukemia in Nordic Countries. J Occup Environ Med. 2012 Oct 30.
Torfadottir JE, Steingrimsdottir L, Mucci L, Aspelund T, Kasperzyk JL, Olafsson O, Fall K, Tryggvadottir L, Harris TB, Launer L, Jonsson E, Tulinius H, Stampfer M, Adami HO, Gudnason V, Valdimarsdottir UA. Milk intake in early life and risk of advanced prostate cancer. Am J Epidemiol. 2012 Jan 15;175(2):144-53.
Torfadottir JE, Valdimarsdottir UA, Mucci L, Stampfer M, Kasperzyk JL, Fall K, Tryggvadottir L, Aspelund T, Olafsson O, Harris TB, Jonsson E, Tulinius H, Adami HO, Gudnason V, Steingrimsdottir L. Rye bread consumption in early life and reduced risk of advanced prostate cancer. Cancer Causes Control;23(6):941-50.2012.
Tukenova M, Diallo I, Anderson H, Hawkins M, Garwicz S, Sankila R, El Fayech C, Winter D, Rubino C, Adjadj E, Haddy N, Oberlin O, Moller T, Langmark F, Tryggvadottir L, Pacquement H, Svahn-Tapper G, de Vathaire F. Second malignant neoplasms in digestive organs after childhood cancer: a cohort-nested case-control study. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e383-90.
Vidarsdottir H, Möller PH, Jonasson JG, Pfannschmidt J, Gudbjartsson T. Indications and Surgical Outcome Following Pulmonary Metastasectomy – A Nation-wide Study. Thoracic and Cardiovascular Surgeon 2012; 60 (6): 383-389.

Útgefið vísindaefni 2011

Arnadottir M, Jonasson JG, Indridason OS. Encapsulating peritoneal sclerosis with a foreign body reaction. NDT Plus Nephrology Dialysis Transplantation) 2011; 10.1093/ntplus/sfq202.
Arnadottir M, Jonasson JG, Indridason OS. Encapsulating peritoneal sclerosis with a foreign body reaction. NDT Plus (Nephrology Dialysis Transplantation) 2011; 4(2):107-109.
Bergmann OB, Kristjansson G, Jonasson JG, Bjornsson ES. Jaundice due to suspected statin hepatotoxicity: a case series. Digestive Diseases and Sciences 2011; DOI10.1007/s10620-011-1950-1. bls 1-6.
Bosetti C, Scélo G, Chuang SC, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, Hemminki K, Weiderpass E, Pukkala E, Tracey E, Olsen JH, Pompe-Kirn V, Brewster DH, Martos C, Chia KS, Brennan P, Hashibe M, Levi F, Vecchia CL, Boffetta P. High constant incidence of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries. Int J Cancer 2011; 129(1): 173-179.
Jensen KE, Munk C, Sparen P, Tryggvadóttir L, Liaw KL, Dasbach E, Nygård M, Kjaer SK. Women's sexual behavior. Population-based study among 65 000 women from four Nordic countries before introduction of human papillomavirus vaccination. Acta Obstet Gynecol Scand. 2011 Jan 4. doi: 10.1111/j.1600-0412.2010.01066.x.
Joensuu H, Vehtari A, Riihimäki J, Nishida T, Eriksson SS, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C, Bordoni A, Magnusson M, Linke Z, Suffliarsky J, Massimo F, Jonasson JG, Dei Tos AP, Rutkowski P. Risk of gastrointestinal stromal tumour recurrence after surgery: an analysis based on pooled population-based cohorts. Lancet Oncology 2011; DOI:10.1016/s1470-2045(11)70299-6.
Jónasson JG, Hrafnkelsson J, Ólafsdóttir E.Skjaldkirtilskrabbamein á Íslandi tímabilið 1955-2004. Klínísk og meinafræðileg faraldsfræðirannsókn. Læknablaðið 2011; 97: 83-89.
Jónasson JG, Hrafnkelsson J, Ólafsdóttir E. Skjaldkirtilskrabbamein á Íslandi tímabilið 1955-2004. Klínísk og meinafræðileg faraldsfræðirannsókn. Læknablaðið 2011; 97: 83-89.
Jonasson JG. Áður dauðadómur – nú sjúkdómur. Ritstjórnargrein (editorial) Læknablaðið 2011; 97: 141.
Jonsdottir AB, Stefansson OA, Bjornsson J, Jonasson JG, Ogmundsdottir HM, Eyfjord JE. Tetraploidy in BRCA2 breast tumours. Eur J Cancer 2011; DOI:10.1016/j.ejca.2011.11.008
Maule M, Scélo G, Pastore G, Brennan P, Hemminki K, Olsen JH, Tracey E, Pukkala E, Weiderpass Vainio E, Brewster DH, Tamaro S, Chia KS, Pompe-Kirn V, Kliewer EV, Tonita JM, Martos C, Jonasson JG, Merletti F, Boffetta P. Second malignancies after childhood noncentral nervous system solid cancers: results from 13 cancer registries. Int J Cancer 2011; 129: 1940-1952.
Rafnar T, Gudbjartsson DF, Sulem P, Jonasdottir A, Sigurdsson A, Jonasdottir A, Besenbacher S, Lundin P, Stacey SN, Gudmundsson J, Magnusson O, le Roux L, Orlygsdottir G, Helgadottir H, Johannesdottir H, Gylfason A, Tryggvadotir L, Jonasson JG, De Juan A, Mutation in BRIP1 confer high risk of ovarian cancer. Nature Genetics 2011: 43(11): 1104-1107. Advance online publication
Rafnar T, Vermeulen SH, Sulem P, Thorleifsson G, Aben KK, Witjes JA, Grotenhuis AJ, Verhaegh GW, Hulsberger-van de Kaa C, Besenbacher S, Gudbjartsson D, Stacey S, Gudmundsson J, Johannesdottir H, Bjarnason H, Zanon C, Helgadottir H, Jonasson JG, Tryggvado European Genome-Wide Association Study Identifies SLC14A1 as a NewUrinary Bladder Cancer Susceptability Gene. Hum Mol Genet 2011; 20 (21): 4268-4281.
Stacey S, Sulem P, Jonasdottir A, Masson G, Gudmundsson J, Gudbjartsson D, Magnusson OT, Gudjonsson SA, Sigurgeirsson B, Thorisdottir K, Ragnarsson R, Benediktsdottir KR, Nexö BA, Tjönneland A, Overvad K, Rudnai P, Gurzau E, Koppova K, Hemminki K, Correde A Germline Variant in the 3' UTR of TP53 Confers Susceptibility to Common Tumours. Nature Genetics 2011: 43(11): 1098-1103. Advance online publication.
Stefansson OA, Jonasson JG, Bjarnason H, Johannsson OT, Olafsdottir K, Bodvarsdottir SK, Valgeirsdottir S, Eyfjord JE. Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression. Breast Cancer Research 2011; 13:R95
Stefansson OA, Jonasson JG, Olafsdottir K, Hilmarsdottir H, Olafsdottir G,Esteller M, Johannsson OT, Eyfjord JE. Epigenetics 2011:6(5);638-649
Steinarsdóttir M, Guðmundsson IH, Jónasson JG, Olafsdottir E, Eyfjord JE, Ogmundsdottir HM. Cytogenetic multiclonality of breast carcinomas: Association with clinico-pathological characteristics and outcome. Genes Chromosomes and Cancer 2011; 50: 930-939.
Vidarsdottir H, Jonasson JG, Möller PH. Krabbamein í botnlanga á Íslandi 1990-2009 – lýðgrunduð rannsókn. Læknablaðið 2011; 97: 537-542.

Afhending gagna í vísindarannsóknir

Samþykkt 2022

Febrúar

VSN 21-216: Lungnakrabbamein á Íslandi árin 2018-2020 greining, meðferð og horfur. Helgi Birgisson
VSN 22-016: Marksækin og ónæmisörvandi meðferð í meðhöndlun lungnakrabbameina á árunum 2010-2020. Sigurdís Haraldsdóttir
VSN 22-006: Litningabreytileikar í mergæxli á Íslandi og á Norðurlöndum. Sæmundur Rögnvalsson og fl

Mars

VSN 20-194: Gæði brjóstakrabbameinsleitar 1988-2020: Samanburður milli kvenna 40-49 ára og 50-59 ára á gæðum skumunar fyrir brjóstakrabbameini á Íslandi árin 1988 til 2020.
Laufey Tryggvadóttir

Júní

VSN 17-143: Íslenska krabbameinsverkefnið – Rannsókn á erfðafræði mergæxla og skyldra skjúkdóma. Sigurður Yngvi Kristinsson
VSN 18-124: Stökkbreytingar og sviperfðabreytingar í eggjastokka, eggjaleiðara og lífhimnukrabbameini á Íslandi 1980-2017. Stefán Þ Sigurðsson og fl
VSN 18-184: Brjóstakrabbamein Íslenskra karla, meinafræði og vægi stökkbreytinga í DNA viðgerðargenum. Stefán Þ Sigurðsson, Jón Gunnlaugur Jónason, Óskar Þór Jóhannsson og fl

Ágúst

VSN 16-022: Skimun fyrir einstofna góðkynja mótefnahækkun: Lýðgrunduð Slembd klínísk prófun. Sigurður Yngvi Kristinsson
VSN 18-065: Nýrnafrumukrabbamein á Íslandi – Klínísk afturskyggn rannsókn
Tómas Guðbjartsson

Október

VSN 18-029: Íslenska krabbameinsverkefnið - Rannsókn á erfðum Blöðruhálskirtilskrabbamein. Rafn Hilmarsson, Þorvaldur Jónsson og Kári Stefánsson
VSN: 18-070: Íslenska krabbameinsverkefnið - Rannsókn á erfðum krabbameins í nýrum.
Eiríkur Orri Guðmunsson, Þorvaldur Jónsson og Kári Stefánsson
VSN 17-137: Íslenska krabbameinsverkefnið- Rannsókn á ristilsepum og krabbamein í ristli og endaþarmi. Trausti Valdimarsson, Kári Stefánsson, Þorvaldur Jónsson og fl
VSN 17-138: Íslenska krabbameinsverkefnið - Rannsókn á erfðum krabbameins í lungum.
Steinn Jónsson
VSN 17-204: Íslenska krabbameinsverkefnið -Rannsókn á erfðum krabbameins í Skjaldkirtli. Hannes Hjartarson og fl

Nóvember

VSN 22-092: Algengi DPYD erfðabreytileika í íslensku þjóðinni og tengsl við aukaverkanir af völdum 5-FU lyfjameðferðar. Sigurdís Haraldsdóttir og Elsa Jónsdóttir
VSN 22-115: Survival after curatively intended treatment of esophageal cancer in the Nordic countries. Bjarni Geir Viðarsson

Samþykkt 2018-2021

Samþykkt 2021

Janúar

Uppræting lifrabólgu C á Íslandi.
Leyfi VSN 15-184. Ábyrgðarmaðu Sigurður Ólafsson

Febrúar

Faraldsfræði krabbameins í skjaldkirtli, samanburður á meðferð og meðferðaárangri við Svíþjóð.
Leyfi VSN-17-191-V2. Ábyrgðarmaður Geir Tryggvasson
Faraldsfræði krabbameina í höfði og hálsi i, samanburður á meðferð og meðferðaárangri við Svíþjóð.
Leyfi VSN-17-190-V2. Ábyrgðarmaður Geir Tryggvasson
Notkun, árangur og fylgikvillar neoadjuvant krabbameinsmeðferðar við þvagblöðrukrabbameini á Íslandi.
Leyfi VSN 21-029. Ábyrgðarmaður Sigurður Guðjónsson

Mars

Íslenska Krabbameinsverkefnið- Rannsókn á erfðafaraldsfræði brjóstakrabbameina
Leyfi VSN 18-115. Ábyrgðarmaður Kári Stefánsson
Íslenska Krabbameinsverkefnið- Rannsókn á faraldsfræði og erfðum sortuæxla og hyrnisfrumukrabbameina.
Leyfi VSN 20-004. Ábyrgðarmaður Kári Stefánsson

Apríl

Faraldsfræði krabbameina og þátttaka í skimun meðal kvenkyns innflytjenda á Norðurlöndunum, af öðrum uppruna en vestrænum. Cancer epidemiology and screening participation among non-Western immigrant women in the Nordic countries.
Leyfi VSN 20-204. Ábyrgðarmaður Laufey Tryggvadóttir
Ástæður og upplýsingagjöf fyrir PSA-mælingu meðal karlmanna.
Leyfi VSN 21-050. Ábyrgðarmaður Heiðdís B. Valdimarsdóttir

Maí

Greining og horfur sjúklinga með liframeinvörp frá ristil- og endaþarmskrabbameinum.
Leyfi VSN 21-097. Ábyrgðarmaður Kristín Huld Haraldsdóttir
Hefur warfarin verndandi áhrif á myndun krabbameins?
Leyfi VSN 19-199. Ábyrgðarmaður Einar Stefán Björnsson

Ágúst

Íslenska Krabbameinsverkefnið – Rannsókn á erfðum krabbameins í blöðruhálskirtili.
Leyfi VSN 18-029. Ábyrgðarmenn Kári Stefánsson og Rafn Hilmarsson
Íslenska Krabbameinsverkefnið – Rannsókn á erfðum krabbameins í nýrum.
Leyfi VSN 18-070. Ábyrgðarmenn Kári Stefánsson og Eiríkur Orri Guðmundsson

September

Nýgengi krabbameina eftir starfi á Íslandi – norrænt sastarfsverkefni.
Leyfi VSN 20-157. Ábyrgðarmaður Jóhanna Eyrún Torfadóttir
Íslenska krabbameinsverkefnið – Erfðir lungnakrabbameins.
Leyfi VSN 17-138. Ábyrgðarmaður Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á krabbameini í brisi.
Leyfi VSN 20-016. Ábyrgðarmaður Kári Stefánsson
Íslenska krabbameinsverkefnið - Rannsókn á erfðum illkynja og góð æxla í legbol.
Leyfi VSN 17-124. Ábyrgðarmaður Kári Stefánsson
Íslenska krabbameinsverkefnið - Rannsókn á krabbameini í leghálsi og forstigum þess.
Leyfi VSN 17-172. Ábyrgðarmaður Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á ristilsepum og krabbamein í ristli og endaþarmi.
Leyfi VSN 17-137. Ábyrgðarmaður Kári Stefánsson
Íslenska krabbameinsverkefnið - Leit að erfðaþáttum sjaldgæfari krabbameina og æxla.
Leyfi VSN 17-166. Ábyrgðarmaður Kári Stefánsson
Íslenska krabbameinsverkefnið - Rannsókn á erfðum góðkynja og illkynja æxla í eggjastokkum.
Leyfi VSN 17-171. Ábyrgðarmaður Kári Stefánsson
Íslenska krabbameinsverkefnið - Rannsókn á skorpulifur og illkynja og góðkynja æxlum í lifur gallblöðru og gallvegum.
Leyfi VSN 18-148. Ábyrgðarmaður Kári Stefánsson
Íslenska krabbameinsverkefnið - Rannsókn á krabbameini í þvagblöðru.
Leyfi VSN 18-137. Ábyrgðarmaður Kári Stefánsson

Október

Nýrnafrumukrabbamein á Íslandi - klínísk afturskyggn rannsókn.
Leyfi VSN 18-065-S2. Ábyrgðarmaður Tómas Guðbjartsson

Nóvember

Íslenska krabbameinsverkefnið- rannsókn á magakrabbameini.
Leyfi VSN 18-097. Ábyrgðarmaður Kári Stefánsson
Horfur Ristil- og endaþarmskrabbameinssjúklinga á blóðþynningu.
Leyfi Vsn 14-162-V1. Ábyrgðarmaður Einar Stefán Björnsson
Skimun fyrir einstofna góðkynja mótefnahækkun: Lýðgrunduð slembd klínísk prófun.
Leyfi VSN 16-022. Ábyrgðarmaður Sigurður Yngvi Kristinsson

Desember

Nordic Helicobacter Pylori Eradication Project (NordHePEP) Norræn rannsókn á áhrifum upprætingar Helicobacter pylori sýkinga.
Leyfi VSN 19-181. Ábyrgðarmaður Helgi Birgisson

Samþykkt 2020

Janúar

Íslenska Krabbameinsverkefnið - Rannsókn á magakrabbameini
Leyfi VSN 18-097. Ábyrðarmenn Þorvaldur Jónsson og Kári Stefánsson
Samspil Erfða og umhverfisþátta við tilurð og afdrif sjúklinga sem tengjast BRCA breytingum
Leyfi VSN. 06-057-V8. Ábyrgðarmaður Stefáns Sigurðsson

Febrúar

Íslenska Krabbameinsverkefnið - Rannsókn á krabbameini í brisi
Leyfi VSN 20-016. Ábyrðarmenn Einar S. Björnsson og Kári Stefánsson

Briskrabbamein á Íslandi árin 2010-2019 – Nýgengi, greiining, meðferð og lifun
Leyfi VSN 20-009. Ábyrgðarmaður Einar S. Björnsson
Fylgikvillar við aðgerð krabbameins hjá sjúklingum með ristil- og endaþarmskrabbamein
VSN 16-196-V4. Ábyrgðarmaður Helgi Birgisson
Greining, stigun og meðferð sjúklinga með krabbamein í maga og vélinda á Íslandi 2012-2019
VSN 19-217 Ábyrgðarmaður Aðalsteinn Arnarson

Mars

Vefjalitanir örvefjasneiða frá brjóstakrabbameinum“.
Leyfi VSN 17-242. Ábyrgðarmaður Sigríður Klara Böðvarsdóttir
Framsýn ransókn á snemmkominni endurkomutíðni krabbameins í þvagblöðru
VSN 19-100-V1. Ábyrgðarmaður Sigurður Guðjónsson

Apríl

Skimun fyrir Lynch heilkenni með alhliða litun fyrir misræmispróteinum í ristil-, endaþarms og legbolskrabbameinum
VSN 20-046. Ábyrgðarmaður Sigurdís Haraldsdóttir

Maí

Lífstíll á mismunandi æviskeiðum og áhætta á krabbameini síðar á ævinni
VSN 17-189-V1. Ábyrgðarmaður Jóhanna Eyrún Torfadóttir

Júní

Áttavitinn-- reynsla einstaklinga með krabbamein af greiningar- og meðferðarferlinu.
Leyfi VSN 20-006. Ábyrgðarmaður Jóhanna Eyrún Torfadóttir
Brjóstakrabbamein íslenskra karla, meinafræði og vægi stökkbreytinga í DNA viðgerðargenum.
Leyfi VSN 18-184. Ábyrgðarmaður Stefán Þ. Sigurðsson
Nýgengi, algengi og horfur carcinoid æxla og annarra taugainnkirtlaæxla á Íslandi.
Leyfi VSN 16-208-V1. Ábyrgðarmaður Einar Stefán Björnsson
Sarkmein á Íslandi 2000-2019.
Leyfi VSN 20-063. Ábyrgðarmaður Halldór Jónsson
Íslenska krabbameinsverkefnið – Rannsókn á vefjafræðilegum eiginleikum krabbameinsæxla og tengsl þeirra við arfgenga erfðabreytileika.
Leyfi VSN 18-142. Ábyrgðarmenn Bjarni Agnar Agnarsson og Kári Stefánsson
Íslenska krabbameinsverkefnið – Rannsókn á erfðum krabbameins í lungum.
Leyfi VSN 17-138. Ábyrgðarmenn Steinn Jónsson og Kári Stefánsson
Íslenska Krabbameinsverkefnið – Rannsókn á erfðum krabbameins í nýrum.
Leyfi VSN 18-070. Ábyrgðarmenn Eiríkur Orri Guðmundsson, Þorvaldur Jónsson og Kári Stefánsson

Ágúst

Íslenska Krabbameinsverkefnið – Rannsókn á erfðum krabbameins í blöðruhálskirtili.
Leyfi VSN 18-029. Ábyrgðarmenn Rafn Hilmarsson, Þorvaldur Jónsson og Kári Stefánsson

September

The use of autolgous steam cell transplanation in muliple myeloma in the Nordic countries in the last decade and changes in survisval over timie (NMSG).
Leyfi VSN-20-092. Ábyrgðarmaður Sigrún Þorsteinsdóttir
Skimun fyrir einstofna góðkynja mótefnahækkun: Lýðgrunduð slembd klínísk prófun.
Leyfi VSN 16-022. Ábyrgðarmaður Sigurður Yngvi Kristinsson
Íslenska Krabbameinsverkefnið - Rannsókn á erfðum góðkynja og illkynja æxla í eggjastokkum.
Leyfi VSN 17-171. Ábyrgðarmenn Karl Ólafsson, Þorvaldur Jónsson og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á erfðum illkynja og góðkynja æxla í legbol.
Leyfi VSN 17-124. Ábyrgðarmenn Karl Ólafsson, Þorvaldur Jónsson og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á krabbameini í leghálsi og forstigum þess.
Leyfi VSN 17-172. Ábyrgðarmenn Karl Ólafsson, Þorvaldur Jónsson og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á ristilsepum og krabbamein í ristli og endaþarmi.
Leyfi VSN 17-137. Ábyrgðarmenn Trausti Valdimarsson, Þorvaldur Jónsson og Kári Stefánsson
Leit að fleirri erfðavísum tengdum brjóstakrabbameini.
Leyfi VSN-11-105. Ábyrgðarmaður Rósa Björk Barkardóttir

Nóvember

Nordic Helicobacter Pylori Eradication Project (NordHePEP) Norræn rannsókn á áhrifum upprætingar Helicobacter pylori sýkinga.
Leyfi VSN- 19-181. Ábyrgðarmaður Helgi Birgisson

Samþykkt 2019

Janúar

Íslenska krabbameinsverkefnið-Rannsókn á vefjafræðilegum eiginleikum krabbameinsæxla og tengsl þeirra við arfgenga erfðabreytileika
Leyfi VSN 18-142. Ábyrgðarmenn Bjarni Agnar Agnarsson og Kári Stefánsson
Incidence of overall and site-specific cancers in bDMARD treated patients with psoriatic arthritis: A population based cohort study from the Nordic countries (PAN-Nordic Rheumatology Register Network)
Leyfi VSN 17-048-V4. Ábyrgðarmaður Björn Guðbjörnsson
Legbolskrabbamein á Íslandi- leghálskrabbamein
Leyfi VSN 15-019-V2. Ábyrgðarmaður Ásgeir Thoroddsen

Febrúar

Greining, meðferð og horfur sjúklinga með krabbamein eða meinvarp í lifur, gallvegum og gallblöðru.
Leyfi VSN 18-192. Ábyrgðarmaður Kristín Huld Haraldsdóttir
Íslenska Krabbameinsverkefnið-Leit að erfðaþáttum sjaldgæfari krabbameina og æxla
Leyfi VSN 17-166-V1. Ábyrgðarmenn Gunnar Bjarni Ragnarsson og Kári Stefánsson
Æxli í munnvatnskirtlum á Íslandi tímabilið 1985-2015
Leyfi VSN 18-187. Ábyrgðarmaður Geir Tryggvason

Mars

Brjóstakrabbamein íslenskra karla, meinafræði og vægi stökkbreytinga í DNA viðgerðargenum.
Leyfi VSN 18-184. Ábyrgðarmaður Stefán Þ. Sigurðsson
Non Hodgkins eitilfrumukrabbamein á Íslandi 1990-2015: Meinafræði og faraldsfræði rannsókn
Leyfi VSN 19-042. Ábyrgðarmaður Bjarni Agnar Agnarsson
Stökkbreytingar og sviperfðabreytingar í eggjastokka-, eggjaleiðarar og lífhimnukrabbameini á Íslandi 1980-2017
Leyfi VSN 18-124. Ábyrgðarmaður Stefán Þ. Sigurðsson
Íslenska Krabbameinsverkefnið- Rannsókn á erfðafaraldsfræði brjóstakrabbameina
Leyfi 18-115. Ábyrgðarmenn Óskar Þór Jóhannsson og Kári Stefánsson
Ris og hnig nýgengi sortuæxla á Íslandi árin 2010-2018
Leyfi VSN 19-035. Ábyrgðarmenn Helgi Sigurðsson og Eir Andradóttir

Apríl

Skimun fyrir einstofna góðkynja mótefnahækkun: Lýðgrunduð slembd klínísk prófun
Leyfi VSN 16-022. Ábyrgðarmaður Sigurður Yngvi Kristinsson

Maí

Íslenska Krabbameinsverkefnið - Rannsókn á erfðum krabbameins í skjaldkirtli
Leyfi VSN 17-204. Ábyrgðarmenn Hannes Hjartarson, Þorvaldur Jónson og Kári Stefánsson
Íslenska Krabbameinsverkefnið – Rannsókn á erfðum krabbameins í blöðruhálskirtili
Leyfi VSN 18-029. Ábyrgðarmenn Rafn Hilmarsson, Þorvaldur Jónsson og Kári Stefánsson
Íslenska Krabbameinsverkefnið – Rannsókn á erfðum krabbameins í nýrum
Leyfi VSN 18-070. Ábyrgðarmenn Eiríkur Orri Guðmundsson, Þorvaldur Jónsson og Kári Stefánsson

Júní

engin gögn afhent í Vísindarannsóknir

Júlí

Taugatróðsæxli á Íslandi 1999-2016
Leyfi VSN 19-074. Ábyrgðarmaður Ingvar Hákon Ólafsson

Október

Horfur ristil og endþarmskrabbameinssjúklinga á blóðþynningu
Leyfi VSN 14-162-V1. Ábyrgðarmaður Einar S. Björnsson
Leit að fleirri erfðavísum tengdum brjóstakrabbameini
Leyfi VSN-11-105. Ábyrgðarmaður Rósa Björk Barkardóttir
Lifraskaði af völdum krabbameinslyfja
Leyfi VSN 17-169-V1. Ábyrgðarmaður Einar S Björnsson

Desember

Erfðir heilsufars í kjölfar áfalla
Leyfi VSN 16-156-V1 &V3. Ábyrgðarmenn Unnur A Valdimarsdóttir og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Leit að erfðaþáttum sjaldgæfra krabbameina
Leyfi VSN 17-166, 17-166-V1&V2. Ábyrgðarmenn Gunnar Bjarni Ragnarsson, Þorvaldur Jónsson og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á erfðum góðkynja og illkynja æxla í eggjastokkum
Leyfi VSN 17-171. Ábyrgðarmenn Karl Ólafsson, Þorvaldur Jónsson og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á erfðum illkynja og góðkynja æxla í legbol
Leyfi VSN 17-124. Ábyrgðarmenn Karl Ólafsson, Þorvaldur Jónsson og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á krabbameini í leghálsi og forstigum þess
Leyfi VSN 17-172. Ábyrgðarmenn Karl Ólafsson, Þorvaldur Jónsson og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á erfðum lungnakrabbameins
Leyfi VSN 17-138. Ábyrgðarmenn Steinn Jónsson, Þorvaldur Jónsson og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á ristilsepum og krabbamein í ristli og endaþarmi
Leyfi VSN 17-137. Ábyrgðarmenn Trausti Valdimarsson, Þorvaldur Jónsson og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á krabbameini í þvagblöðru
Leyfi VSN 18-137. Ábyrgðarmenn Sigurður Guðjónsson, Þorvaldur Jónson og Kári Stefánsson

Samþykkt 2018

Janúar

Íslenska Krabbameinsverkefnið - Rannsókn á erfðafræði hæggengra blóðmeina
Leyfi VSN 17-145 Ábyrgðarmenn Brynjar Viðarsson, Þorvaldur Jónsson og Kári Stefánsson

Íslenska Krabbameinsverkefnið - Rannsókn á erfðafræði eitlakrabbameina
Leyfi VSN 17-199 Ábyrgðarmenn Bjarni Agnar Agnarsson, Þorvaldur Jónsson og Kári Stefánsson

Íslenska Krabbameinsverkefnið - Rannsókn á erfðafræði mergæxla og skyldra blóðsjúkdóma
Leyfi VSN 17-143. Ábyrgðarmenn Sigurður Yngvi Kristinsson, Þorvaldur Jónsson og Kári Stefánsson

Samspil erfða og umhverfisþátta við tilurð og afdrif sjúklinga með krabbamein sem tengjast BRCA breytingum
Leyfi VSN 06-057-V8. Ábyrgðarmaður Jórunn Erla Eyfjörð

Febrúar

Áhættuþættir HPV- tengdra sjúkdóma og kynfæravarta hjá islenskum konum. Spurningakönnun
Leyfi VSN 17-050-V4. Ábyrgðarmaður Laufey Tryggvadóttir

Fylgikvillar við aðgerð krabbameins hjá sjúklingum með ristil- og endaþarmskrabbamein
Leyfi VSN 16-196-V2. Ábyrgðarmaður Helgi Birgisson
Íslenska Krabbameinsverkefnið - Rannsókn á bráðahvítblæði
Leyfi VSN 17-144. Ábyrgðarmenn Sigrún Reykdal, Þorvaldur Jónsson og Kári Stefánsson
Nýgengi krabbameina meðal flugáhafna
Leyfi 15-034. Ábyrgðarmaður Vilhjálmur Rafnsson
Samanburður á ductal cancer in situ brjóstakrabbameini milli Íslands og Svíþjóðar með tilliti til meðferðar og fleiri þátta gæðaskráningar
Leyfi VSN 17-003-V2. Ábyrgðarmaður Ásgerður Sverrisdóttir

Mars

Legbolskrabbamein á Íslandi
Leyfi VSN 15-019-V3. Ábyrgðarmaður Ásgeir Thoroddsen
Fjölþjóðleg ferilrannsókn á brjóstakrabbameini hjá konum 40 ára og yngri við greiningu
Leyfi VSN-17-154. Ábyrgðarmaður Laufey Tryggvadóttir

Rannsókn á uppsöfnuðum áhrifum ofþyngdar á krabbameinsbyrði byggð á ferilhóp Leitarstöðvar og Krabbameinsskrá þar sem beitt er aldurs-tímabils-fæðingarhóps nálgun
Leyfi VSN 13-125-V2. Ábyrgðarmaður Laufey Tryggvadóttir

Apríl

Íslenska Krabbameinsverkefnið - Erfðir blöðruhálskirtilskrabbameins
Leyfi VSN 18-029. Ábyrgðarmenn Rafn Hilmarsson, Þorvaldur Jónsson og Kári Stefánsson

Lymfoma og önnur krabbamein í tengslum við ónæmisbælandi meðferð með ónæmisbælandi lyfjum axathioprine og TNF alfa hemlum
Leyfi VSN 18-040. Ábyrgðarmaður Einar S. Björnsson
Lifraskaði af völdum krabbameinslyfja
Leyfi VSN 17-169. Ábyrgðarmenn Einar S Björnsson og Helgi Kristinn Björnsson

Maí

Áhættuþættir HPV- tengdra sjúkdóma og kynfæravarta hjá islenskum konum. Spurningakönnun
Leyfi VSN 17-050-V3. Ábyrgðarmaður Laufey Tryggvadóttir
Skimun fyrir einstofna góðkynja mótefnahækkun: Lýðgrunduð slembd klínísk prófun
Leyfi VSN 16-022. Ábyrgðarmaður Sigurður Yngvi Kristinsson

Júní

Húðkrabbamein á Íslandi önnur en sortuæxli: Faraldsfræði, meinafræði og ættfræði í heilu þýði
Leyfi VSN 18-071. Ábyrgðarmenn Jón Gunnlaugur Jónasson og Jónas Aðalsteinsson
Íslenska Krabbameinsverkefnið - Leit að erfðaþáttum sjaldgæfra krabbameina
Leyfi VSN 17-166. Ábyrgðarmenn Gunnar Bjarni Ragnarsson, Þorvaldur Jónsson og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á erfðum lungnakrabbameins
Leyfi VSN 17-138. Ábyrgðarmenn Steinn Jónsson, Þorvaldur Jónsson og Kári Stefánsson

Júlí

Afdrif sjúklinga með krabbamein í efri þvagvegum á Íslandi á árunum 2003-2016
Leyfi VSN 18-005. Ábyrgðarmenn Sigurður Guðjónsson og Oddur Björnsson

September

Erfðir heilsufars í kjölfar áfalla-The genetics of morbidity and survival in response to significant life stressors
Leyfi VSN 16-156. Ábyrgðarmenn Unnur A Valdimarsdóttir og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á erfðum góðkynja og illkynja æxla í eggjastokkum
Leyfi VSN 17-171. Ábyrgðarmenn Karl Ólafsson, Þorvaldur Jónsson og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á krabbameini í leghálsi og forstigum þess
Leyfi VSN 17-172. Ábyrgðarmenn Karl Ólafsson, Þorvaldur Jónsson og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á erfðum illkynja og góðkynja æxla í legbol
Leyfi VSN 17-124. Ábyrgðarmenn Karl Ólafsson, Þorvaldur Jónsson og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á magakrabbameini
Leyfi VSN 18-097. Ábyrgðarmenn Þorvaldur Jónson, Agnes Smáradóttir og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á erfðum skjaldkirtilskrabbamein
Leyfi VSN 17-204. Ábyrgðarmenn Hannes Hjartarson, Þorvaldur Jónson og Kári Stefánsson
Íslenska Krabbameinsverkefnið - Rannsókn á krabbameini í þvagblöðru
Leyfi VSN. 18-137. Ábyrgðarmenn Sigurður Guðjónsson , Þorvaldur Jónson og Kári Stefánsson
Lifrafrumukrabbamein á Íslandsi 1998-2017
Leyfi VSN 15-167-V1. Ábyrgðarmaður Jón Gunnlaugur Jónasson

Október

Íslenska Krabbameinsverkefnið - Rannsókn á ristilsepum og krabbamein í ristli og endaþarmi
Leyfi VSN 17-137. Ábyrgðarmenn Trausti Valdimarsson, Þorvaldur Jónsson og Kári Stefánsson

Krabbamein í smágirni á Íslandi
Leyfi VSN-18-139. Ábyrgðarmaður Páll Helgi Möller
Stökkbreytingar og sviperfðabreytingar í eggjastokka-, eggjaleiðara og lífhimnukrabbameini, á Íslandi 1980-2017
Leyfi VSN 18-124. Ábyrgðarmaður Stefán Þ. Sigurðsson

Nóvember

Þáttur svefns og meltóníns í blöðruhálskirtilskrabbamein
Leyfi VSN 09-143-V5. Ábyrgðarmaður Unnur Anna Valdimarsdóttir
Íslenska Krabbameinsverkefnið - - Rannsókn á skorpulifur og illkynja og góðkynja æxlum í lifur, gallblöðru og gallvegum
Leyfi VSN 18-148. Ábyrgðarmenn Einar S Björnsson, Þorvaldur Jónsson og Kári Stefánsson

Desember

Eggjastokkakrabbamein á Íslandi 2005-2014
Leyfi VSN 16-002. Ábyrgðarmaður Elísabet Arna Helgadóttir

Afhending tölulegra upplýsinga

Who – Health for All: Algengi og árlega tíðni (fjöldatölur sendar til Embætti landlæknis)
Embætti Landlæknis: Lýðheilsuvísar, útreiknað aldursstaðlað nýgengi eftir heilbrigðisumdæmum
NORDCAN: Nýgengi og dánartíðni (töflugögn send til skrifstofu NORDCAN hjá dönsku krabbameinsskránni)
NOMESCO: Fjöldatölur eftir aldri (töflugögn send til Embætti landlæknis)

Nemendaverkefni

2023

Stærð brjóstakrabbameinsæxla við greiningu: Samanburður á stærð skimunargreinda og klínískt greindra æxla og milli Íslands og Svíþjóðar
Hildur Gyða Grétarsdóttir https://skemman.is/handle/1946/44226

Greining og meðferð sjúklinga með krabbamein í legbol
Oddný Rósa Ásgeirsdóttir https://skemman.is/handle/1946/44221
Brjóstakrabbamein – tengsl BRCA2 stökkbreytingar við tímasetningu og staðsetningu fjarmeinvarpa
Helga Sif Guðmundsdóttir https://skemman.is/handle/1946/44254

2022

Lungnakrabbamein á Íslandi árið 2019. Greining, meðferð og horfur
Guðrún Anna Halldórsdróttir https://skemman.is/handle/1946/41259

Greining, meðferð og horfur briskrabbameina á Íslandi.
Sigurður Karlsson

2021

Skjaldkirtilskrabbamein á Íslandi 2009-2020: Endurkomutíðni, horfur og meðferð
Katrín Kristínsdóttir http://hdl.handle.net/1946/38447

Krabbamein á höfði og hálsi á Íslandi 2009-2020: Nýgengi, meðferð og horfur
Aníta Rut Kristjánsdóttir http://hdl.handle.net/1946/38392

Greining, meðferð og uppvinnsla við krabbameini í blöðruhálskirtli á Íslandi 2017-2020. Samanburður gæðavísa við Svíþjóð
Hafsteinn Örn Guðjónsson http//hdl.handle.net/1946/38487

2020

Gæðaskráning vélindakrabbameina á Íslandi 2012-2019. Samanburður milli tímabila og við gæðaskráningu í Svíþjóð.
Einar Daði Lárusson http://hdl.handle.net/1946/35689

Greining og meðferð sjúklinga með krabbamein í ristli- og endaþarmi árin 2014-2018
Þórður Líndal Þórsson http://hdl.handle.net/1946/35654

2019

Skjaldkirtilskrabbamein á Íslandi 2009-2016: Endurkomutíðni, horfur og meðferð
Dagbjört Aðalsteinsdóttir https://skemman.is/handle/1946/33095
Endurkomutíðni, meðferð og horfur sjúklinga með krabbamein á höfði og hálsi á Íslandi 2009-2016
Edda Rún Gunnarsdóttir https://skemman.is/handle/1946/33077
Ris og hnig nýgengis sortuæxla á Íslandi
Eir Andradóttir https://skemman.is/handle/1946/33090
Greining, meðferð og horfur sjúklinga með krabbamein eða meinvörp í lifur, gallgöngum eða gallblöðru 2013-2017
Rakel Hekla Sigurðardóttir https://skemman.is/handle/1946/33089

2018

Meðferð og gæðaskráning við krabbameini í endaþarmi á Íslandi 2016
Þorvaldur Bollason https://skemman.is/handle/1946/30413
Samanburður á ífarandi brjóstakrabbameini milli Íslands og Svíþjóðar með tilliti til meðferðar og fleiri þátta gæðaskráningar
Lilja Dögg Gísladóttir https://skemman.is/handle/1946/30359
Sviperfðabreytingar í eggjastokkakrabbameini
Sigurður Ingi Magnússon https://skemman.is/handle/1946/31448

2017

Ductal carcinoma in situ á Íslandi 2008-2014 og samanburður greiningar og meðferðar við Svíþjóð
Andri Snær Ágústsson https://skemman.is/handle/1946/27585
Fylgikvillar aðgerða hjá sjúklingum með ristil- og endaþarmskrabbamein
Einar Bragi Árnason https://skemman.is/handle/1946/30413

Styrkir til vísindarannsókna

Nordic Cancer Union

Lög og reglur um vísindarannsóknir

Lög um vísindarannsóknir á heilbrigðissviði (lög nr. 44/2014)
Reglugerð um skipulag vísindarannsókna á heilbrigðissviði (rg. Nr. 520/2018)

Reglugerð um hvernig velja má og nálgast fólk til þátttöku í vísindarannsóknum á heilbrigðissviði og hvaða fræðslu skuli veita því áður en samþykkis þess er leitað (rg.nr. 230/2018)
Lög um landlækni og lýðheilsu (lög nr. 41/2007)
Reglugerð um heilbrigðisskrár (rg. 548/2008)

Lög um réttindi sjúklinga (lög nr. 74/1997)
Lög um sjúkraskrár (lög nr. 55/2009)
Reglugerð um sjúkraskrár (rg. 550/2015)
Lög um lífsýnasöfn og um söfn heilbrigðiupplýsinga (lög nr. 110/2000)
Reglugerð um vörslu og nýtingu lífsýna í lífsýnasöfnum (rg. 1146/2010)
Lög um Persónuvernd og vinnslu persónuupplýsinga (lög nr. 90/2018)
Reglur um flutning persónuupplýsinga til annarra landa (nr. 228/2010)
Reglur um meðferð persónuupplýsinga við framkvæmd erfðarannsókna (nr. 1100/2008)
Reglur um tilkynningarskyldu og leyfisskyldu vinnslu persónuupplýsinga (nr. 712/2008)
Reglur um öryggi persónuupplýsinga (nr. 299/2001)
Reglur um hvernig afla skal upplýsts samþykkis fyrir vinnslu persónuupplýsnga í vísindaransóknir (nr. 170/2001)